Axon Enterprise (AXON) 10-Q6 May 142014 Q1 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2014	Apr. 25, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Entity Registrant Name	'TASER INTERNATIONAL INC	'
Entity Central Index Key	'0001069183	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	53,866,585

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current Assets:	'	'
Cash and cash equivalents	$45,133	$42,271
Short-term investments	17,700	9,101
Accounts and notes receivable, net of allowance of $200 as of March 31, 2014 and December 31, 2013	20,501	22,488
Inventory, net	13,252	11,109
Prepaid expenses and other current assets	9,398	5,397
Deferred income tax assets, net	7,101	7,101
Total current assets	113,085	97,467
Property and equipment, net	18,398	19,043
Deferred income tax assets, net	12,001	13,679
Intangible assets, net	3,264	3,317
Goodwill	2,235	2,235
Long-term investments	14,674	12,023
Other assets	1,105	618
Total assets	164,762	148,382
Current Liabilities:	'	'
Accounts payable	7,013	6,221
Accrued liabilities	9,407	8,840
Current portion of deferred revenue	7,414	6,878
Customer deposits	543	1,154
Current portion of capital lease payable	37	36
Total current liabilities	24,414	23,129
Deferred revenue, net of current portion	14,112	13,341
Liability for unrecorded tax benefits	1,837	3,122
Other long-term liabilities	555	376
Long-term portion of capital lease payable	58	67
Total liabilities	40,976	40,035
Commitments and Contingencies	'	'
Stockholders' Equity	'	'
Preferred stock, $0.00001 par value per share; 25 million shares authorized; no shares issued at March 31, 2014 and December 31, 2013	'	'
Common stock, $0.00001 par value per share; 200 million shares authorized; 53,994,484 and 52,725,247 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively	1	1
Additional paid-in capital	151,461	139,424
Treasury stock at cost, 16,412,755 shares at March 31, 2014 and December 31, 2013	-92,203	-92,203
Retained earnings	64,519	61,127
Accumulated other comprehensive income (loss)	8	-2
Total stockholders' equity	123,786	108,347
Total liabilities and stockholders' equity	$164,762	$148,382

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]	'	'
Allowance on accounts receivable	$200	$200
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	53,994,484	52,725,247
Common stock, shares outstanding	53,994,484	52,725,247
Treasury stock, shares	16,412,755	16,412,755

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations and Comprehensive Income (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]	'	'
Net sales	$36,185	$30,434
Cost of products sold and services delivered	13,977	11,983
Gross margin	22,208	18,451
Sales, general and administrative expenses	13,746	11,181
Research and development expenses	3,606	2,013
Income from operations	4,856	5,257
Interest and other income (expense), net	30	-23
Income before provision for income taxes	4,886	5,234
Provision for income taxes	1,495	1,936
Net income	3,391	3,298
Income per common and common equivalent shares	'	'
Basic	$0.06	$0.06
Diluted	$0.06	$0.06
Weighted average number of common and common equivalent shares outstanding	'	'
Basic	53,190	52,746
Diluted	55,124	54,600
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME	'	'
Net income	3,391	3,298
Foreign currency translation adjustments	10	-18
Comprehensive income	$3,401	$3,280

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash Flows from Operating Activities:	'	'
Net income	$3,391	$3,298
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	1,162	1,419
Loss (gain) on write down / disposal of property and equipment, net	15	-29
Loss on disposal of intangibles	80	96
Bond premium amortization	192	'
Provision for doubtful accounts	1	'
Provision for excess and obsolete inventory	7	46
Provision for warranty	306	169
Stock-based compensation expense	1,177	923
Deferred income taxes	6,401	1,732
Provision for unrecognized tax benefits	-1,285	58
Excess tax benefit from stock-based compensation	-4,723	-1,910
Change in assets and liabilities:	'	'
Accounts and notes receivable	1,986	1,294
Inventory	-2,150	-894
Prepaid Expenses and other assets	-4,574	-1,134
Accounts payable and accrued liabilities	1,628	-2,093
Deferred revenue	1,307	1,659
Customer deposits	-611	-115
Net cash provided by operating activities	4,310	4,519
Cash Flows from Investing Activities:	'	'
Purchases of investments	-13,822	'
Proceeds from call / maturity of investments	2,380	1,680
Purchases of property and equipment	-799	-383
Proceeds from disposal of fixed assets	'	34
Purchases of intangible assets	-67	-104
Net cash provided by (used in) investing activities	-12,308	1,227
Cash Flows from Financing Activities:	'	'
Repurchase of common stock	'	-5,351
Proceeds from options exercised	7,275	307
Payroll tax payments for net-settled stock awards	-1,138	-178
Excess tax benefit from stock-based compensation	4,723	1,910
Payments on capital lease obligation	-8	-8
Net cash provided by (used in) financing activities	10,852	-3,320
Effect of exchange rate change on cash and cash equivalents	8	27
Net increase in cash and cash equivalents	2,862	2,453
Cash and cash equivalents, beginning of period	42,271	36,127
Cash and cash equivalents, end of period	45,133	38,580
Supplemental Disclosure:	'	'
Cash paid for income taxes-net	50	50
Non-Cash Transactions:	'	'
Property and equipment purchases in accounts payable	$114	$227

Organization_and_Summary_of_Si

Organization and Summary of Significant Accounting Policies	3 Months Ended
Organization and Summary of Significant Accounting Policies	Mar. 31, 2014
Accounting Policies [Abstract]	'
Organization and Summary of Significant Accounting Policies	'
	1. Organization and Summary of Significant Accounting Policies
	TASER International, Inc. (the “Company” or “TASER” or “we” or “our”) is a developer and manufacturer of advanced conducted electrical weapons (“CEWs”) designed for use in law enforcement, federal, military, corrections, private security and personal defense. In addition, the Company has developed full technology solutions for the capture, storage and management of video/audio evidence as well as other tactical capabilities for use in law enforcement. The Company sells its products worldwide through its direct sales force, distribution partners, online store and third-party resellers. The Company was incorporated in Arizona in September 1993, and reincorporated in Delaware in January 2001. The Company’s corporate headquarters and manufacturing facilities are located in Scottsdale, Arizona. The Company’s software development business unit facilities are located in Santa Barbara, California, and Seattle, Washington.
	The accompanying condensed consolidated financial statements include the accounts of the Company, and its wholly owned subsidiaries, including TASER International Europe SE (“TASER Europe”). TASER Europe was established in 2009 to facilitate sales and provide customer service to our customers in the European region. All material intercompany accounts, transactions, and profits have been eliminated.
	a. Basis of presentation, preparation and use of estimates
	These unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information related to the Company’s organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) has been condensed or omitted. The accounting policies followed in the preparation of these unaudited condensed consolidated financial statements are consistent with those followed in the Company’s annual consolidated financial statements for the year ended December 31, 2013, as filed on Form 10-K. In the opinion of management, these unaudited condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments, necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with the Company’s Form 10-K for the year ended December 31, 2013. The results of operations for the three months ended March 31, 2014 and 2013 are not necessarily indicative of the results to be expected for the full year (or any other period). Significant estimates and assumptions in these condensed consolidated financial statements include:

		•		product warranty reserves,

		•		inventory valuation reserves,

		•		revenue recognition allocated in multiple-deliverable revenue recognition,

		•		valuation of goodwill, intangibles and long-lived assets,

		•		recognition, measurement and valuation of current and deferred income taxes,

		•		fair value of stock awards issued, the estimated vesting period for performance-based stock awards and forfeiture rates, and

		•		recognition and measurement of contingencies and accrued litigation expense.
	Actual results could differ materially from those estimates.
	b. Segment information
	The Company is comprised of two reportable segments: the sale of CEWs, accessories and other related products and services (the “TASER Weapons” segment); and the video business which includes the TASER Cam, AXON video products and EVIDENCE.com (the “EVIDENCE.com & Video” segment). Reportable segments are determined based on discrete financial information reviewed by the Company’s Chief Executive Officer who is the Chief Operating Decision Maker (the “CODM”) for the Company. The Company organizes and reviews operations based on products and services, and currently, there are no operating segments that are aggregated. The Company performs an annual analysis of its reportable segments. Additional information related to the Company’s segments is summarized in Note 13.

	c. Geographic information and major customers
	For the three months ended March 31, 2014 and 2013, net sales by geographic area were as follows:


			Three Months Ended March 31,
			2014						2013
	United States		$	25,576			71	%	$	27,314	90	%
	Other Countries			10,609			29			3,120	10

	Total		$	36,185			100	%	$	30,434	100	%

	Sales to customers outside of the United States are typically denominated in U.S. dollars and are attributed to each country based on the shipping address of the distributor or customer. For the three months ended March 31, 2014 and 2013, no individual country outside of the United States represented greater than 10% of total net sales. Sales in the international market generally are larger and occur more intermittently than in the domestic market due to the profile of the Company’s customers.
	For the three months ended March 31, 2014, no customers represented more than 10% of total net sales. In the three months ended March 31, 2013, one distributor represented approximately 13.7% of total net sales. At March 31, 2014, the Company had receivables from two customers comprising approximately 11.0% and 10.3% of its aggregate accounts receivable balance, respectively. At December 31, 2013, the Company had a receivable from one customer comprising 17.4% of the aggregate accounts receivable balance.
	d. Income per common share
	Basic income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the periods presented. Diluted income per share is calculated based on the weighted average number of common shares outstanding for the period plus the dilutive effect of stock options and restricted stock units using the treasury stock method. The calculation of the weighted average number of shares outstanding and income per share are as follows (in thousands except per share data):


			Three Months Ended March 31,
			2014			2013
	Numerator for basic and diluted earnings per share:
	Net income		$	3,391		$	3,298

	Denominator:
	Weighted average shares outstanding—basic			53,190			52,746
	Dilutive effect of stock-based awards			1,934			1,854

	Diluted weighted average shares outstanding			55,124			54,600

	Anti-dilutive stock-based awards excluded			315			1,232

	Net income per common share:
	Basic		$	0.06		$	0.06
	Diluted		$	0.06		$	0.06
	e. Revenue recognition
	The Company derives revenue from two primary sources: (1) the sale of physical products, including our CEWs, AXON cameras, corresponding extended warranties, and related accessories such as cartridges and batteries, and (2) subscription to our EVIDENCE.com digital evidence management Software-as-a-Solution (“SaaS”) (including data storage fees and other ancillary services), which includes varying levels of support. To a lesser extent, the Company also recognizes training and other revenue. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, title has transferred, the price is fixed and collectability is reasonably assured. Extended warranty revenue, SaaS revenue and related data storage revenue are recognized ratably over the term of the contract beginning on the commencement date of each contract.

	Revenue arrangements with multiple deliverables are divided into separate units and revenue is allocated using the relative selling price method based upon vendor-specific objective evidence of selling price, or third-party evidence of the selling prices if vendor-specific objective evidence of selling prices does not exist. If neither vendor-specific objective evidence nor third-party evidence exists, management uses its best estimate of selling price.
	The Company offers customers the right to purchase extended warranties that include additional services and coverage beyond the limited warranty for certain products. Revenue for extended warranty purchases is deferred at the time of sale and recognized over the warranty period commencing on the date of sale. Extended warranties range from one to five years.
	EVIDENCE.com and AXON cameras are sold separately, but in most instances are purchased together. In these instances, customers typically purchase and pay for the equipment and one year of EVIDENCE.com in advance. Additional years of service are generally billed annually over a specified service term, which has typically ranged from one to five years. AXON equipment has stand-alone value and represents a deliverable that is provided to the customer at the time of sale, while EVIDENCE.com services are provided over the specified term of the contract. The Company recognizes revenue for the AXON equipment at the time of the sale consistent with the discussion of multiple deliverable arrangements above. Revenue for EVIDENCE.com is deferred at the time of the sale and recognized over the service period. In certain circumstances, not all requirements are met for the recognition of revenue relative to equipment sold in conjunction with EVIDENCE.com at the time the equipment is provided to customers. In such circumstances, based on limitations associated with the consideration, the revenue may be recognized ratably over the specified term of the contract, or when all conditions for revenue recognition are met, if sooner.
	In 2012, the Company introduced a program, the TASER Assurance Program (“TAP”) whereby a customer purchasing a product and joining the program will have the right to trade-in the original product for a new product of the same or like model in the future. Upon joining TAP, customers also receive an extended warranty for the initial products purchased and spare inventory. Under this program the customer generally pays additional annual installments over the contract period, generally three to five years. The Company records consideration received related to the future purchase as deferred revenue until all revenue recognition criteria are met, which is generally at the end of the contract period.
Sales tax collected on sales is netted against government remittances and thus, recorded on a net basis. Training revenue is recorded as the service is provided.
Deferred revenue consists of billings and/or payments received in advance related to products and services for which the criteria for revenue recognition have not yet been met. Deferred revenue that will be recognized during the succeeding twelve month period is recorded as current deferred revenue and the remaining portion is recorded as long-term. Deferred revenue does not include future revenue from multi-year contracts for which no invoice has yet been created. Generally, customers are billed in annual installments. See Note 5 for further discussion of the Company’s deferred revenue.
Sales are typically made on credit and the Company generally does not require collateral. Management performs ongoing credit evaluations of its customers’ financial condition and maintains an allowance for estimated potential losses. Uncollectable accounts are charged to expense when deemed uncollectible, and accounts and notes receivable are presented net of an allowance for doubtful accounts. This allowance represents management’s best estimate and is based on their judgment after considering a number of factors, including third-party credit reports, actual payment history, cash discounts, customer-specific financial information and broader market and economic trends and conditions.
The Company may, from time to time, enter into agreements with its customers to finance a customer’s purchases with a note receivable that may range in terms up to five years. Sales are recorded at the fair value of the note, which is generally sold and assigned to a third-party financing company. The terms of the assignments are such that the Company expects to receive payment within 30 days of the original sale. The assignments are non-recourse and the Company has no obligations or continuing involvement with the notes receivable. Prior to entering into an assignment, the Company evaluates the credit quality and financial condition of the third-party financing company. As of March 31, 2014 and December 31, 2013 there was $0.2 million and $0 in accounts and notes receivable related to such arrangements, respectively. The Company did not record any interest income on notes receivable due to minimal holding periods, nor has the Company recognized gains or losses upon the assignment of the notes.

f. Warranty costs
The Company warrants its CEWs, StrikeLight, AXON cameras and Evidence Transfer Management systems (“ETMs”) from manufacturing defects on a limited basis for a period of one year after purchase and, thereafter, will replace any defective unit for a fee. Estimated costs for the standard warranty are charged to cost of products sold and services delivered when revenue is recorded for the related product. Future warranty costs are estimated based on historical data related to returns and warranty costs on a quarterly basis and this rate is applied to current product sales. Historically, reserve amounts have been increased if management becomes aware of a component failure that could result in larger than anticipated returns from customers. The accrued warranty liability expense is reviewed quarterly to verify that it sufficiently reflects the remaining warranty obligations based on the anticipated expenditures over the balance of the warranty obligation period, and adjustments are made when actual warranty claim experience differs from estimates. Costs related to extended warranties are charged to cost of products sold and services delivered when incurred.
The reserve for warranty returns is included in accrued liabilities on the condensed consolidated balance sheets. The three months ended March 31, 2014 includes additional expense due to a change in estimate regarding the Company’s first generation ETM as a result of an updated version launched in the first quarter. Changes in the Company’s estimated product warranty liabilities are as follows (in thousands):


		Three Months Ended March 31,
		2014			2013
Balance, January 1,		$	955		$	484
Utilization of accrual			(174	)		(157	)
Warranty expense			306			169

Balance, March 31,		$	1,087		$	496

g. Fair value of financial instruments
The Company uses the fair value framework that prioritizes the inputs to valuation techniques for measuring financial assets and liabilities measured on a recurring basis and for non-financial assets and liabilities when these items are re-measured. Fair value is considered to be the exchange price in an orderly transaction between market participants, to sell an asset or transfer a liability at the measurement date. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. The Company categorizes each of its fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

	•		Level 1 – Valuation techniques in which all significant inputs are unadjusted quoted prices from active markets for assets or liabilities that are identical to the assets or liabilities being measured.

	•		Level 2 – Valuation techniques in which significant inputs include quoted prices from active markets for assets or liabilities that are similar to the assets or liabilities being measured and/or quoted prices for assets or liabilities that are identical or similar to the assets or liabilities being measured from markets that are not active. Also, model-derived valuations in which all significant inputs and significant value drivers are observable in active markets are Level 2 valuation techniques.

	•		Level 3 – Valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Unobservable inputs are valuation technique inputs that reflect our own assumptions about the assumptions that market participants would use in pricing an asset or liability.
The Company has cash equivalents and investments, which at March 31, 2014 and December 31, 2013, were comprised of money market funds, state and municipal obligations, corporate bonds, and certificates of deposits. See additional disclosure regarding the fair value of the Company’s cash equivalents and investments in Note 2. Included in the balance of other assets as of March 31, 2014 is $0.6 million related to corporate-owned life insurance policies which are used to fund the Company’s deferred compensation plan. The Company determines the fair value of its insurance contracts by obtaining the cash surrender value of the contracts from the issuer, a Level 2 valuation technique.
The Company’s financial instruments also include accounts and notes receivable, accounts payable and accrued liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.
h. Impairment of Long-Lived Assets
Management evaluates whether events and circumstances have occurred that indicate the remaining estimated useful life of long-lived assets and identifiable intangible assets may warrant revision or that the remaining balance of these assets may not be recoverable. Such circumstances could include, but are not limited to, a change in the product mix, a change in the way products are created, produced or delivered, or a significant change in the way products are branded and marketed. In performing the review for recoverability, management estimates the future undiscounted cash flows expected to result from the use of the assets and their eventual disposition. The amount of the impairment loss, if impairment exists, is calculated based on the excess of the carrying amounts of the assets over their estimated fair value computed using discounted cash flows. No impairment losses were recorded in the three months ended March 31, 2014 and 2013.

i. Recently issued accounting guidance
In July 2013, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update (“ASU”) to standardize the balance sheet presentation of unrecognized tax benefits. This update applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. The new guidance is effective for fiscal years beginning after December 15, 2013, and early adoption is allowed. The adoption of this guidance resulted in an immaterial reclassification on the Company’s consolidated balance sheet.

Cash_Cash_Equivalents_and_Inve

Cash, Cash Equivalents, and Investments	3 Months Ended
Cash, Cash Equivalents, and Investments	Mar. 31, 2014
Cash And Cash Equivalents [Abstract]	'
Cash, Cash Equivalents, and Investments	'
	2. Cash, cash equivalents, and investments
	The following is a summary of cash, cash equivalents and held-to-maturity investments by type at March 31, 2014 and December 31, 2013 (in thousands):


		March 31, 2014									December 31, 2013
		Amortized Cost		Gross		Gross			Fair Value		Amortized Cost		Gross		Gross			Fair Value
				Unrealized		Unrealized							Unrealized		Unrealized
				Gains		Losses							Gains		Losses
	Cash and money market funds	$	44,897	$	—	$	—		$	44,897	$	42,226	$	—	$	—		$	42,226
	State and municipal obligations		15,213		24		—			15,237		10,807		14		—			10,821
	Corporate bonds		14,781		5		(19	)		14,767		7,743		2		(14	)		7,731
	Certificates of deposit		2,616		—		—			2,616		2,619		—		—			2,619

	Total cash, cash equivalents and investments	$	77,507	$	29	$	(19	)	$	77,517	$	63,395	$	16	$	(14	)	$	63,397

	The Company believes the unrealized losses on the Company’s investments are due to interest rate fluctuations. As these investments are either short-term in nature, are expected to be redeemed at par value and/or because the Company has the ability and intent to hold these investments to maturity, the Company does not consider these investments to be other than temporarily impaired at March 31, 2014. None of Company’s investments have been in an unrealized loss position for more than one year.
	The following table summarizes the amortized cost and fair value of the short-term and long-term investments held by the Company at March 31, 2014 by contractual maturity (in thousands):


		Amortized Cost		Fair Value
	Due in less than one year	$	17,700	$	17,706
	Due after one year, through two years		14,674		14,677

	Total short-term and long-term investments	$	32,374	$	32,383

	Fair Value Measurement
	The following table presents information about the Company’s investments that are measured at fair value as of March 31, 2014, and indicates the fair value hierarchy of the valuation (in thousands):


		Amortized		Quoted Prices		Siginificant			Significant		Total Fair
		Cost		in Active		Other			Unbservable		Value
				Markets for		Observable			Inputs
				Identical		Inputs			(Level 3)
				Assets		(Level 2)
				(Level 1)
	Cash	$	40,827	$	40,827	$	—		$	—	$	40,827
	Money market funds		4,070		4,070		—			—		4,070
	Certificates of deposit		2,616		—		2,616			—		2,616
	Corporate bonds		14,781		14,767		—			—		14,767
	State and municipal obligations		15,213		—		15,237			—		15,237

	Total cash, cash equivalents and investments	$	77,507	$	59,664	$	17,853		$	—	$	77,517

Inventory

Inventory	3 Months Ended
Inventory	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Inventory	'
	3. Inventory
	Inventories are stated at the lower of cost or market. Cost is determined using the weighted average cost of raw materials, which approximates the first-in, first-out (“FIFO”) method, and includes allocations of manufacturing labor and overhead. Provisions are made to reduce potentially excess, obsolete or slow-moving inventories to their net realizable value. Inventories as of March 31, 2014 and December 31, 2013, consisted of the following (in thousands):


		March 31,			December 31,
		2014			2013
	Raw materials	$	9,201		$	7,376
	Work-in-process		80			44
	Finished goods		4,943			4,688
	Reserve for excess and obsolete inventory		(972	)		(999	)

	Total inventory	$	13,252		$	11,109

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	3 Months Ended
Goodwill and Intangible Assets	Mar. 31, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets	'
	4. Goodwill and Intangible assets
	In the fourth quarter of 2013, the Company recorded goodwill related to the Familiar business acquisition. Goodwill is calculated as the excess of the purchase price over the fair value of the identifiable tangible and intangible assets. The balance of goodwill at both March 31, 2014 and December 31, 2013 was $2.2 million.
	Intangible assets consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):


				March 31, 2014							December 31, 2013
		Useful Life		Gross		Accumulated			Net		Gross		Accumulated			Net Carrying
				Carrying		Amortization			Carrying		Carrying		Amortization			Amount
				Amount					Amount		Amount
	Amortized:
	Domain names	5 Years		$	125	$	(105	)	$	20	$	125	$	(102	)	$	23
	Issued patents	4 to 15 Years			1,557		(456	)		1,101		1,529		(441	)		1,088
	Issued trademarks	9 to 11 Years			372		(159	)		213		437		(147	)		290

	Total amortized				2,054		(720	)		1,334		2,091		(690	)		1,401

	Not amortized:
	TASER trademark				900					900		900					900
	Patents and trademarks pending				1,030					1,030		1,016					1,016

	Total not amortized				1,930					1,930		1,916					1,916

	Total intangible assets			$	3,984	$	(720	)	$	3,264	$	4,007	$	(690	)	$	3,317

	Amortization expense relative to intangible assets for the three months ended March 31, 2014 and 2013 was approximately $40,000 and $38,000, respectively. Estimated amortization expense of intangible assets for the remaining nine months of 2014, the next five years ended December 31, and thereafter is as follows (in thousands):


	2014 (remaining nine months)	$	121
	2015		153
	2016		146
	2017		143
	2018		133
	2019		123
	Thereafter		515

	Total	$	1,334

Deferred_Revenue

Deferred Revenue	3 Months Ended
Deferred Revenue	Mar. 31, 2014
Revenue Recognition [Abstract]	'
Deferred Revenue	'
	5. Deferred Revenue
	Deferred revenue consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):


		March 31		December 31,
		2014		2013
	Warranty	$	16,525	$	15,889
	EVIDENCE.com		4,471		4,026
	Other		530		304

	Total deferred revenue		21,526		20,219
	Total current portion of deferred revenue		7,414		6,878

	Total long-term portion of deferred revenue	$	14,112	$	13,341

	Included in the current portion of deferred revenue at March 31, 2014 is approximately $2.1 million related to EVIDENCE.com and $5.3 million related to warranties. For more information relating to the Company’s revenue recognition policies please refer to Note 1(e).

Accrued_Liabilities

Accrued Liabilities	3 Months Ended
Accrued Liabilities	Mar. 31, 2014
Payables And Accruals [Abstract]	'
Accrued Liabilities	'
	6. Accrued liabilities
	Accrued liabilities consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):


		March 31,		December 31,
		2014		2013
	Accrued salaries and benefits	$	2,188	$	2,328
	Accrued judgments and settlements		3,300		3,350
	Accrued warranty expense		1,087		955
	Accrued income and other taxes		140		233
	Other accrued expenses		2,692		1,974

	Accrued liabilities	$	9,407	$	8,840

Income_Taxes

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	7. Income taxes
	Deferred Tax Assets
	The net deferred income tax assets at March 31, 2014, include capitalized research and development costs, research and development tax credits, non-qualified stock-based compensation expense, deferred warranty revenue, warranty and inventory reserves, accrued vacation, and other items, partially offset by accelerated depreciation expense. The Company’s total current and long-term net deferred tax assets at March 31, 2014 are $19.1 million.
	In preparing the Company’s condensed consolidated financial statements, management assesses the likelihood that its deferred tax assets will be realized from future taxable income. In evaluating the Company’s ability to recover its deferred income tax assets, management considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction by jurisdiction basis. A valuation allowance is established if it is determined that it is more likely than not that some portion or all of the net deferred tax assets will not be realized. Management exercises significant judgment in determining its provisions for income taxes, its deferred tax assets and liabilities, and its future taxable income for purposes of assessing its ability to utilize any future tax benefit from its deferred tax assets. Although management believes that its tax estimates are reasonable, the ultimate tax determination involves significant judgments that could become subject to audit by tax authorities in the ordinary course of business, as well as the generation of sufficient future taxable income. Management has determined that it is more likely than not that future sales and profitability will allow for the utilization of the deferred tax assets. However, the deferred tax asset could be reduced or a valuation allowance could be recorded in the near-term if estimates of future taxable income during the carry forward period change.

	The Company has completed research and development tax credit studies which identified approximately $10.1 million in tax credits for federal, Arizona and California income tax purposes related to the 2003 through 2014 tax years. Management has made the determination that it is more likely than not that the full benefit of the R&D tax credit will not be sustained on examination and recorded a liability for unrecognized tax benefits of $3.0 million as of March 31, 2014. In addition, management accrued approximately $0.1 million for estimated uncertain tax positions related to certain state income tax liabilities. As of March 31, 2014 management does not expect the amount of the unrecognized tax benefit liability to increase or decrease significantly within the next 12 months. Should the unrecognized tax benefit of $3.1 million be recognized, the Company’s effective tax rate would be favorably impacted. Approximately $1.3 million of the unrecognized tax benefit associated with research and development credits has been netted against the research and development credit deferred tax asset.
	Effective Tax Rate
	The Company’s overall effective tax rate for the three months ended March 31, 2014, after discrete period adjustments, was 30.6%. Before discrete adjustments the tax rate was 39.1%, which is above the statutory rate due to the impact of state taxes and non-deductible expenses for items such as Incentive Stock Option (“ISO”) expense, meals and entertainment and lobbying fees, but also reduced by the domestic production activities deduction, which net makes our projected annual net income for tax purposes higher than our book pre-tax income.

Stockholders_Equity

Stockholders' Equity	3 Months Ended
Stockholders' Equity	Mar. 31, 2014
Equity [Abstract]	'
Stockholders' Equity	'
	8. Stockholders’ equity
	Stock Option Activity
	On May 23rd, 2013, the Company’s stockholders approved a new stock incentive plan authorizing an additional 1.6 million shares, plus remaining available shares under a prior plan for issuance under the new plan. Combined with the legacy stock incentive plans, there are approximately 2.0 million shares available for grant as of March 31, 2014.
	Performance-based stock awards
	The Company has issued performance-based stock options and performance-based restricted stock units (“RSUs”), the vesting of which is contingent upon the achievement of certain performance criteria related to the operating performance of the Company as well as successful and timely development and market acceptance of future product introductions. In addition, certain of the performance RSUs have additional service requirements subsequent to the achievement of the performance criteria. Compensation expense is recognized over the implicit service period (the longer of the period the performance condition is expected to be achieved or the required service period) based on management’s estimate of the probability of the performance criteria being satisfied, adjusted at each balance sheet date.
	Restricted Stock Units
	The following table summarizes RSU activity for the three months ended March 31, 2014 (aggregate intrinsic value in thousands):


		Number of			Weighted		Aggregate
		Units			Average Grant-		Intrinsic Value
					Date Fair
					Value
	Units outstanding, beginning of period		1,279,123		$	9.67
	Granted		374,947			17.58
	Released		(302,194	)		7.51
	Forfeited		(107,070	)		13.57

	Units outstanding, end of period		1,244,806			12.25	$	22,768

	Aggregate intrinsic value represents the Company’s closing stock price on the last trading day of the period, which was $18.29 per share on March 31, 2014, multiplied by the number of RSUs. As of March 31, 2014, there was $12.9 million in unrecognized compensation cost related to RSUs granted under our stock plans. We expect to recognize this cost over a weighted average period of 31.5 months. RSUs are released when vesting requirements are met.

	In the three months ended March 31, 2014, the Company granted approximately 0.1 million performance-based RSUs (included in the table above). Of the approximately 0.3 million performance-based RSUs outstanding as of March 31, 2014, the performance criteria have been met for approximately 0.1 million units, which will vest upon the completion of service requirements. The performance-based RSUs granted in 2014 contain provisions whereby the amount of RSUs that ultimately vest is dependent upon the level of achievement of performance metrics. The amount of shares included in the table above related to such grants is the target level, which is the Company’s best estimate of the amount of RSUs that will vest. The maximum additional shares that could be earned is approximately 0.1 million, which are not included in the table above.
	Certain RSUs that vested in the first quarter of 2014 were net-share settled such that the Company withheld shares with value equivalent to the employees’ minimum statutory obligation for the applicable income and other employment taxes, and remitted the cash to the appropriate taxing authorities. Total shares withheld were approximately 0.1 million with a value of approximately $1.1 million on their respective vesting dates as determined by the Company’s closing stock price on such dates. Payments for the employees’ tax obligations are reflected as a financing activity within the statement of cash flows. These net-share settlements had the effect of share repurchases by the Company as they reduced the amount of shares that would have otherwise been issued as a result of the vesting.
	Stock Options
	The following table summarizes stock option activity for the three months ended March 31, 2014 (aggregate intrinsic value in thousands):


		Number of			Weighted		Average		Aggregate
		options			Average		Remaining		Intrinsic Value
					Exercise Price		Contractual
							Life (years)
	Options outstanding, beginning of period		3,365,692		$	6.15
	Granted		—
	Exercised		(1,027,600	)		7.08
	Expired / forfeited		(27,134	)		9.77

	Options outstanding, end of period		2,310,958			5.69		5.02	$	29,213

	Exercisable at March 31, 2014		2,200,443			5.75		4.95		27,697

	Expected to vest after March 31, 2014		68,150			4.49		7.02		940

	Aggregate intrinsic value represents the difference between the exercise price of the underlying stock option awards and the closing market price of the Company’s common stock of $18.29 on March 31, 2014. The aggregate intrinsic value of options exercised for the three months ended March 31, 2014 and 2013 was approximately $12.6 million and $1.6 million, respectively. As of March 31, 2014, total unrecognized stock-based compensation expense related to unvested stock options was approximately $0.1 million, which is expected to be recognized over a remaining weighted average period of approximately 10 months. Options expected to vest are presented net of expected forfeitures.
	Included in the table above is approximately 0.4 million of performance-based options of which, less than 40,000 are unvested and are expected to vest. The Company does not expect to recognize any future expense related to performance-based stock options.
	Share Based Compensation Expense
	When granted, the Company calculates the fair value of stock options using the Black-Scholes-Merton option pricing valuation model, which incorporates various assumptions including volatility, expected life and risk-free interest rates. No options were awarded during the three month periods ended March 31, 2014 or 2013. The estimated fair value of stock-based compensation awards is amortized to expense on a straight-line basis over the service periods. As stock-based compensation expense recognized is based on awards ultimately expected to vest, it is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company’s forfeiture rate was calculated based on its historical experience of awards which ultimately vested.

	Share-based compensation was classified as follows (in thousands):


		Three Months Ended March 31,
		2014			2013
	Cost of products sold	$	22		$	34
	Sales, general and administrative expenses		711			731
	Research and development expenses		444			158

	Total share-based compensation	$	1,177		$	923

	Total share-based compensation expense recognized in the statements of operations for the three months ended March 31, 2014 and 2013, included approximately $8,000 and $39,000, respectively, related to incentive stock options for which no tax benefit is recognized.

Line_of_Credit

Line of Credit	3 Months Ended
Line of Credit	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Line of Credit	'
	9. Line of credit
	The Company has a $10.0 million revolving line of credit with a domestic bank. As of March 31, 2014, the Company had letters of credit outstanding of $0.6 million under the facility and available borrowing of $9.4 million. The line is secured by the Company’s accounts receivable and inventory, and bears interest at varying rates (currently LIBOR plus 1.5% to prime). The line of credit matures on June 30, 2015, and requires monthly payments of interest only. At March 31, 2014 and December 31, 2013, there were no borrowings under the line of credit. The Company’s agreement with the bank requires it to comply with certain financial and other covenants including maintenance of minimum tangible net worth and a fixed charge coverage ratio. The ratio of total liabilities to tangible net worth can be no greater than 1:1, and the fixed charge coverage ratio, as defined in the line of credit, can be no less than 1.25:1, based upon a trailing twelve-month period. At March 31, 2014, the Company’s tangible net worth ratio was 0.34:1 and its fixed charge coverage ratio was 3.26:1, and accordingly, the Company was in compliance with these covenants.

Commitments_and_Contingencies

Commitments and Contingencies

3 Months Ended

Mar. 31, 2014

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

10. Commitments and contingencies

Product Litigation

The Company is currently named as a defendant in 18 lawsuits in which the plaintiffs allege either wrongful death or personal injury in situations in which a TASER CEW was used (or present) by law enforcement officers in connection with arrests or during training exercises. In addition, one other product litigation matter in which the Company is involved is currently on appeal. While the facts vary from case to case, the product liability claims are typically based on an alleged product defect resulting in injury or death, usually involving a failure to warn, and the plaintiffs are seeking monetary damages. The information throughout this note is current through the filing date of this Quarterly Report on Form 10-Q.

As a general rule, it is the Company’s policy not to settle suspect injury or death cases. Exceptions are sometimes made where the settlement is strategically beneficial to the Company. Also, on occasion, the Company’s insurance company has settled such lawsuits over the Company’s objection where the risk is over the Company’s liability insurance deductibles. Due to the confidentiality of our litigation strategy and the confidentiality agreements that are executed in the event of a settlement, the Company does not generally identify or comment on which specific lawsuits have been settled or the amount of any settlement.

In 2009, the Company implemented new risk management strategies, including revisions to product warnings and training to better protect both the Company and its customers from litigation based on ‘failure to warn’ theories – which comprise the vast majority of the cases against the Company. These risk management strategies have been highly effective in reducing the rate and exposure from litigation post-2009. From the third quarter of 2011 to the first quarter of 2014, product liability cases have been reduced from 55 active to 18 active cases.

Management believes that pre-2009 cases have a different risk profile than cases which have occurred since the risk management procedures were introduced in 2009. Therefore, the Company necessarily treats certain pre-2009 cases as exceptions to the Company’s general no settlement policy in order to reduce caseload, legal costs and liability exposure. The Company intends to continue its successful practice of aggressively defending and generally not settling litigation except in very limited and unusual circumstances as described above.

Turner (NC) lawsuit

The Turner (NC) lawsuit was tried in July 2011 and resulted in a jury verdict of $10.0 million against the Company. The Company filed post-trial motions seeking judgment as a matter of law notwithstanding the verdict and in the alternative, a new trial or alternatively, a remittitur of the jury award. Based on this verdict, the Company recorded litigation judgment expense of $3.3 million in 2011. During March 2012, the Federal District Court for the Western District of North Carolina granted the Company’s motion for remittitur and ordered the reduction of the original jury award from $10.0 million to approximately $4.4 million after offsets. On April 20, 2012, the court issued an order which adjusted the award to $5.5 million. On May 4, 2012, the court issued another order which entered judgment in the amount of $5.5 million plus costs and post-judgment interest. Based on this action by the court, the Company reversed a portion of the previously accrued litigation judgment during the year ended December 31, 2012, which resulted in a benefit of $2.2 million during the twelve months ended December 31, 2012, and leaving a reserve of $1.1 million on the Company’s balance sheet as of December 31, 2012.

The Company appealed this verdict. On November 11, 2013, the U.S. Court of Appeals for the Fourth Circuit issued its opinion affirming the district court’s judgment upholding the jury verdict imposing liability on the Company for its negligence and vacating the district court’s judgment with respect to the remitted award of compensatory damages. The Court of Appeals remanded the case to the district court for a new trial limited to the issue of damages. As such, the appellate bond previously required, was subsequently released. The Company subsequently requested a rehearing en banc which was denied by the Court of Appeals. The remanded issues are currently pending in the Federal District Court for the Western District of North Carolina. As of December 31, 2013, the Company’s reserve related to this case was reduced to zero. In the first quarter of 2014, the Company and the Plaintiffs agreed to settle the Turner litigation for $3.4 million, which is a $2.1 million savings compared to the $5.5 million judgment that was vacated on appeal. Insurance will pay $2.7 million and the Company is responsible for the remaining $0.7 million. The Company’s 2008 General and Excess Insurance Policies are now exhausted due to this settlement agreement.

With respect to each of the pending lawsuits, the following table lists the name of plaintiff, the date the Company was served with process, the jurisdiction in which the case is pending, the type of claim and the status of the matter.

Plaintiff

Served

Jurisdiction

Claim Type

Status

Grable

8-Aug

6th Judicial Circuit Court, Pinellas County, FL

Training Injury

Discovery Phase

Koon

8-Dec

17th Judicial Circuit Court, Broward County, FL

Training Injury

Discovery Phase

Derbyshire

9-Nov

Ontario, Canada Superior Court of Justice

Officer Injury

Discovery Phase

Thompson

10-Mar

11th Judicial Circuit Court, Miami-Dade County, FL

Suspect Injury During Arrest

Discovery Phase

Doan

10-Apr

The Queens Bench Alberta, Red Deer Judicial Dist.

Wrongful Death

Discovery Phase

Shymko

10-Dec

The Queens Bench, Winnipeg Centre, Manitoba

Wrongful Death

Pleading Phase

Juran

10-Dec

Hennepin County District Court, 4th Judicial District

Officer Injury

Discovery Phase

Wilson

11-May

US District Court, ED MO

Wrongful Death

Discovery Phase; trial

scheduled for Nov. 2014

Ramsey

12-Jan

17th Judicial Circuit Court, Broward County, FL

Wrongful Death

Discovery Phase

Mitchell

12-Apr

US District Court, ED MI

Wrongful Death

Discovery Phase; trial

scheduled June 2014

Firman

12-Apr

Ontario, Canada Superior Court of Justice

Wrongful Death

Pleading Phase

Ricks

12-May

US District Court, WD LA

Wrongful Death

Motion Phase

Miller

13-Jan

New Castle County Superior Court, DE

Wrongful Death

Discovery Phase

Salgado

13-Feb

US District Court, SD FL

Wrongful Death

Pleading Phase

Slade

13-Dec

US District Court, ED TX

Wrongful Death

Pleading Phase

McCue

14-Mar

US District Court, District of Maine

Wrongful Death

Pleading Phase

Faltesek

14-Apr

Harris County District Court, TX

Wrongful Death

Pleading Phase

Rascom

14-Apr

US District Court, AZ

Wrongful Death

Pleading Phase

In addition, other product litigation matters in which the Company is involved that are currently on appeal are listed below:

Plaintiff

Served

Jurisdiction

Claim Type

Status

Glowczenski

4-Oct

US District Court, ED NY

Wrongful Death

Notice of Appeal filed Sept. 2013; Opening Brief was filed Jan. 2014; Answering Brief is due Apr. 2014.

Cases that were dismissed or judgment entered during the first quarter of 2014 and through the filing date of this Quarterly Report on Form 10-Q are listed in the table below. Cases that were dismissed or judgment entered in prior fiscal quarters are not included in this table.

Plaintiff

Served

Jurisdiction

Claim Type

Status

Athetis

9-May

Superior Court, AZ

Wrongful Death

Motion for Summary Judgment

Duensing

12-Feb

US District Court, NV

Suspect Injury During Arrest

Motion to Dismiss

Wingard

12-Oct

US District Court, WD PA

Wrongful Death

Voluntary Dismissal

Manjares

12-Nov

US District Court, ED WA

Suspect Injury During Arrest

Voluntary Dismissal

Turner

10-Feb

US District Court, ED NC

Wrongful Death

Settled and dismissed

The claims, and in some instances the defense, of each of these lawsuits have been submitted to the Company’s insurance carriers that maintained insurance coverage during the applicable periods. The Company continues to maintain product liability insurance coverage with varying limits and deductibles. The following table provides information regarding the Company’s product liability insurance. Remaining insurance coverage is based on information received from the Company’s insurance provider (in millions).

Policy Year

Policy Start

Policy End

Insurance

Deductible

Defense

Remaining

Active Cases and Cases on Appeal

Date

Coverage

Amount

Costs

Insurance

Covered

Coverage

2004

12/1/03

12/1/04

0.1

Glowczenski

2005

12/1/04

12/1/05

0.3

n/a

2006

12/1/05

12/1/06

0.3

3.7

n/a

2007

12/1/06

12/1/07

0.3

n/a

2008

12/1/07

12/15/08

0.5

—

Grable, Koon

2009

12/15/08

12/15/09

Derbyshire

2010

12/15/09

12/15/10

Thompson, Shymko, Doan, Juran

2011

12/15/10

12/15/11

Wilson

Jan – Jun 2012

12/15/11

6/25/12

Ramsey, Mitchell, Firman, Ricks

Jul – Dec 2012

6/25/12

12/15/12

n/a

2013

12/15/12

12/15/13

Miller, Salgado

2014

12/15/13

12/15/14

Slade, McCue, Rascom, Faltesek

Other Litigation

In January 2011, the Company was served with a complaint in the matter of GEOTAG, Inc. v. TASER International, et. al. that was filed in the U.S. District Court for the Eastern District of Texas, Marshall Division, which alleges that a dealer geographical locator feature on TASER’s website infringes upon plaintiff’s US Patent No. 5,930,474. The complaint seeks a judgment of infringement, a permanent injunction against infringement, an award for damages, costs, expenses and prejudgment and post-judgment interest, and an award for enhanced damages and attorneys’ fees. TASER licensed this locator feature from a third party and has denied liability for infringement. This case has been dismissed as of the first quarter of 2014.

In February 2012, the Company was served with a complaint in the matter of AA & Saba Consultants, Inc. v. TASER International, Inc. that was filed in the Superior Court for the County of Maricopa, Arizona, which alleges that the Company breached a contract by unilaterally terminating a distributor agreement between the Company and plaintiff without good cause. The complaint sought an award for damages, costs, expenses and attorneys’ fees. TASER filed a counterclaim for breach of contract and fraud. During 2012, the Company made a settlement offer of $0.8 million to plaintiff which was recorded as an expense in SG&A. The offer was not accepted and thereafter was withdrawn. On February 28, 2014, the jury returned a verdict of $3.3 million against the Company. Judgment had not been entered at the time of this filing and the judgment is subject to an award of attorneys’ fees. The Company believes the verdict is not supported by the evidence and intends to appeal. The Company recorded an additional $2.6 million of expense in the fourth quarter of 2013. Should the plaintiff be awarded reimbursement of legal fees, additional expense will be recorded by the Company.

General

From time to time, the Company is notified that it may be a party to a lawsuit or that a claim is being made against it. It is the Company’s policy to not disclose the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on the Company. After carefully assessing the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend any lawsuit filed against the Company. The Company does not expect these lawsuits to individually, or in the aggregate, materially affect our business, results of operations or financial condition. However, the outcome of any litigation is inherently uncertain and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters will be covered by our insurance or will not be in excess of amounts provided by insurance coverage and will not have a material adverse effect on our business, operating results or financial condition.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	11. Related party transactions
	The Company engages Mark Kroll, a member of the Board of Directors, to provide consulting services. Expenses relating to these services for the three months ended March 31, 2014 and 2013 were approximately $31,000 and $30,000, respectively. At March 31, 2014 and December 31, 2013, the Company had accrued liabilities for these consulting services of approximately $15,000 and $12,000, respectively.

Employee_Benefit_Plans

Employee Benefit Plans	3 Months Ended
Employee Benefit Plans	Mar. 31, 2014
Compensation And Retirement Disclosure [Abstract]	'
Employee Benefit Plans	'
	12. Employee benefit plans
	The Company has a defined contribution profit sharing 401(k) plan for eligible employees, which is qualified under Sections 401(a) and 401(k) of the Internal Revenue Code of 1986, as amended. Employees are entitled to make tax-deferred contributions of up to the maximum allowed by law of their eligible compensation.
	In addition, during the third quarter of 2013, the Company implemented a non-qualified deferred compensation plan for certain executives, key employees and non-employee directors through which participants may elect to postpone the receipt and taxation of a portion of their compensation, including stock-based compensation, received from the Company. The non-qualified deferred compensation plan allows eligible participants to defer up to 80% of their base salary and up to 100% of other types of compensation. The plan also allows for (i) matching and discretionary employer contributions and (ii) the deferral of vested RSU awards. Employee deferrals are deemed 100% vested upon contribution. Distributions from the plan are made upon retirement, death, separation of service, specified date or upon the occurrence of an unforeseeable emergency. Distributions can be paid in a variety of forms from lump sum to installments over a period of years. Participants in the plan are entitled to select from a wide variety of investments available under the plan and are allocated gains or losses based upon the performance of the investments selected by the participant. All gains or losses are allocated fully to plan participants and the Company does not guarantee a rate of return on deferred balances. Assets related to this plan consist of corporate-owned life insurance contracts and are included in other assets in the consolidated balance sheets. Participants have no rights or claims with respect to any plan assets and any such assets are subject to the claims of the Company’s general creditors.
	Contributions to the plans are made by both the employee and the Company. Company contributions are based on the level of employee contributions and are immediately vested. The Company’s matching contributions to the 401(k) plan for the three months ended March 31, 2014 and 2013, were both approximately $0.2 million. The Company expects to make matching contributions to the non-qualified deferred compensation plan related to the three months ended March 31, 2014, of approximately $8,000. Future matching or profit sharing contributions to the plans are at the Company’s sole discretion.

Segment_Data

Segment Data	3 Months Ended
Segment Data	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment Data	'
	13. Segment data
	The Company’s operations are comprised of two reportable segments: the sale of CEWs, accessories and other products and services (the “TASER Weapons” segment); and the video business, which includes the TASER Cam, AXON video products and EVIDENCE.com (the “EVIDENCE.com & Video” segment). The Company includes only revenues and costs directly attributable to the EVIDENCE.com & Video segment in that segment. Included in EVIDENCE.com & Video segment costs are costs of sales for both products and services, overhead allocation based on direct labor, selling expense for the video sales team, video product management expenses, video trade shows and related expenses, and research and development for products included in the EVIDENCE.com & Video segment. All other costs are included in the TASER Weapons segment. The CODM does not review assets by segment as part of the financial information provided; therefore, no asset information is provided in the following tables.
	Information relative to the Company’s reportable segments is as follows (in thousands):


		Three Months Ended March 31, 2014							Three Months Ended March 31, 2013
		TASER		EVIDENCE.com					TASER		EVIDENCE.com
		Weapons		& Video			Total		Weapons		& Video			Total
	Product sales	$	32,475	$	3,038		$	35,513	$	28,003	$	2,180		$	30,183
	Service revenue		—		672			672		—		251			251

	Net sales		32,475		3,710			36,185		28,003		2,431			30,434

	Cost of products sold		10,918		2,656			13,574		10,217		1,188			11,405
	Cost of services delivered		—		403			403		—		578			578

	Gross margin		21,557		651			22,208		17,786		665			18,451
	Sales, general & administrative		11,289		2,457			13,746		10,073		1,108			11,181
	Research & development		817		2,789			3,606		989		1,024			2,013

	Income (loss) from operations	$	9,451	$	(4,595	)	$	4,856	$	6,724	$	(1,467	)	$	5,257

	Purchases of property and equipment	$	697	$	102		$	799	$	254	$	129		$	383
	Purchases of intangible assets		67		—			67		104		—			104
	Depreciation and amortization		1,078		84			1,162		999		420			1,419

Organization_and_Summary_of_Si1

Organization and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2014

Accounting Policies [Abstract]

Basis of Presentation, Preparation and Use of Estimates

a. Basis of presentation, preparation and use of estimates

These unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information related to the Company’s organization, significant accounting policies and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) has been condensed or omitted. The accounting policies followed in the preparation of these unaudited condensed consolidated financial statements are consistent with those followed in the Company’s annual consolidated financial statements for the year ended December 31, 2013, as filed on Form 10-K. In the opinion of management, these unaudited condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments, necessary to fairly state our financial position, results of operations and cash flows for the periods presented and the presentations and disclosures herein are adequate when read in conjunction with the Company’s Form 10-K for the year ended December 31, 2013. The results of operations for the three months ended March 31, 2014 and 2013 are not necessarily indicative of the results to be expected for the full year (or any other period). Significant estimates and assumptions in these condensed consolidated financial statements include:

•

product warranty reserves,

•

inventory valuation reserves,

•

revenue recognition allocated in multiple-deliverable revenue recognition,

•

valuation of goodwill, intangibles and long-lived assets,

•

recognition, measurement and valuation of current and deferred income taxes,

•

fair value of stock awards issued, the estimated vesting period for performance-based stock awards and forfeiture rates, and

•

recognition and measurement of contingencies and accrued litigation expense.

Actual results could differ materially from those estimates.

Segment Information

b. Segment information

The Company is comprised of two reportable segments: the sale of CEWs, accessories and other related products and services (the “TASER Weapons” segment); and the video business which includes the TASER Cam, AXON video products and EVIDENCE.com (the “EVIDENCE.com & Video” segment). Reportable segments are determined based on discrete financial information reviewed by the Company’s Chief Executive Officer who is the Chief Operating Decision Maker (the “CODM”) for the Company. The Company organizes and reviews operations based on products and services, and currently, there are no operating segments that are aggregated. The Company performs an annual analysis of its reportable segments. Additional information related to the Company’s segments is summarized in Note 13.

Geographic Information and Major Customers

c. Geographic information and major customers

For the three months ended March 31, 2014 and 2013, net sales by geographic area were as follows:

Three Months Ended March 31,

2014

2013

United States

25,576

27,314

Other Countries

10,609

3,120

Total

36,185

100

30,434

100

Sales to customers outside of the United States are typically denominated in U.S. dollars and are attributed to each country based on the shipping address of the distributor or customer. For the three months ended March 31, 2014 and 2013, no individual country outside of the United States represented greater than 10% of total net sales. Sales in the international market generally are larger and occur more intermittently than in the domestic market due to the profile of the Company’s customers.

For the three months ended March 31, 2014, no customers represented more than 10% of total net sales. In the three months ended March 31, 2013, one distributor represented approximately 13.7% of total net sales. At March 31, 2014, the Company had receivables from two customers comprising approximately 11.0% and 10.3% of its aggregate accounts receivable balance, respectively. At December 31, 2013, the Company had a receivable from one customer comprising 17.4% of the aggregate accounts receivable balance.

Income Per Common Share

d. Income per common share

Basic income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the periods presented. Diluted income per share is calculated based on the weighted average number of common shares outstanding for the period plus the dilutive effect of stock options and restricted stock units using the treasury stock method. The calculation of the weighted average number of shares outstanding and income per share are as follows (in thousands except per share data):

Three Months Ended March 31,

2014

2013

Numerator for basic and diluted earnings per share:

Net income

3,391

3,298

Denominator:

Weighted average shares outstanding—basic

53,190

52,746

Dilutive effect of stock-based awards

1,934

1,854

Diluted weighted average shares outstanding

55,124

54,600

Anti-dilutive stock-based awards excluded

315

1,232

Net income per common share:

Basic

0.06

Diluted

0.06

Revenue Recognition

e. Revenue recognition

The Company derives revenue from two primary sources: (1) the sale of physical products, including our CEWs, AXON cameras, corresponding extended warranties, and related accessories such as cartridges and batteries, and (2) subscription to our EVIDENCE.com digital evidence management Software-as-a-Solution (“SaaS”) (including data storage fees and other ancillary services), which includes varying levels of support. To a lesser extent, the Company also recognizes training and other revenue. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, title has transferred, the price is fixed and collectability is reasonably assured. Extended warranty revenue, SaaS revenue and related data storage revenue are recognized ratably over the term of the contract beginning on the commencement date of each contract.

Revenue arrangements with multiple deliverables are divided into separate units and revenue is allocated using the relative selling price method based upon vendor-specific objective evidence of selling price, or third-party evidence of the selling prices if vendor-specific objective evidence of selling prices does not exist. If neither vendor-specific objective evidence nor third-party evidence exists, management uses its best estimate of selling price.

The Company offers customers the right to purchase extended warranties that include additional services and coverage beyond the limited warranty for certain products. Revenue for extended warranty purchases is deferred at the time of sale and recognized over the warranty period commencing on the date of sale. Extended warranties range from one to five years.

EVIDENCE.com and AXON cameras are sold separately, but in most instances are purchased together. In these instances, customers typically purchase and pay for the equipment and one year of EVIDENCE.com in advance. Additional years of service are generally billed annually over a specified service term, which has typically ranged from one to five years. AXON equipment has stand-alone value and represents a deliverable that is provided to the customer at the time of sale, while EVIDENCE.com services are provided over the specified term of the contract. The Company recognizes revenue for the AXON equipment at the time of the sale consistent with the discussion of multiple deliverable arrangements above. Revenue for EVIDENCE.com is deferred at the time of the sale and recognized over the service period. In certain circumstances, not all requirements are met for the recognition of revenue relative to equipment sold in conjunction with EVIDENCE.com at the time the equipment is provided to customers. In such circumstances, based on limitations associated with the consideration, the revenue may be recognized ratably over the specified term of the contract, or when all conditions for revenue recognition are met, if sooner.

In 2012, the Company introduced a program, the TASER Assurance Program (“TAP”) whereby a customer purchasing a product and joining the program will have the right to trade-in the original product for a new product of the same or like model in the future. Upon joining TAP, customers also receive an extended warranty for the initial products purchased and spare inventory. Under this program the customer generally pays additional annual installments over the contract period, generally three to five years. The Company records consideration received related to the future purchase as deferred revenue until all revenue recognition criteria are met, which is generally at the end of the contract period.

Sales tax collected on sales is netted against government remittances and thus, recorded on a net basis. Training revenue is recorded as the service is provided.

Deferred revenue consists of billings and/or payments received in advance related to products and services for which the criteria for revenue recognition have not yet been met. Deferred revenue that will be recognized during the succeeding twelve month period is recorded as current deferred revenue and the remaining portion is recorded as long-term. Deferred revenue does not include future revenue from multi-year contracts for which no invoice has yet been created. Generally, customers are billed in annual installments. See Note 5 for further discussion of the Company’s deferred revenue.

Sales are typically made on credit and the Company generally does not require collateral. Management performs ongoing credit evaluations of its customers’ financial condition and maintains an allowance for estimated potential losses. Uncollectable accounts are charged to expense when deemed uncollectible, and accounts and notes receivable are presented net of an allowance for doubtful accounts. This allowance represents management’s best estimate and is based on their judgment after considering a number of factors, including third-party credit reports, actual payment history, cash discounts, customer-specific financial information and broader market and economic trends and conditions.

The Company may, from time to time, enter into agreements with its customers to finance a customer’s purchases with a note receivable that may range in terms up to five years. Sales are recorded at the fair value of the note, which is generally sold and assigned to a third-party financing company. The terms of the assignments are such that the Company expects to receive payment within 30 days of the original sale. The assignments are non-recourse and the Company has no obligations or continuing involvement with the notes receivable. Prior to entering into an assignment, the Company evaluates the credit quality and financial condition of the third-party financing company. As of March 31, 2014 and December 31, 2013 there was $0.2 million and $0 in accounts and notes receivable related to such arrangements, respectively. The Company did not record any interest income on notes receivable due to minimal holding periods, nor has the Company recognized gains or losses upon the assignment of the notes.

Warranty Costs

f. Warranty costs

The Company warrants its CEWs, StrikeLight, AXON cameras and Evidence Transfer Management systems (“ETMs”) from manufacturing defects on a limited basis for a period of one year after purchase and, thereafter, will replace any defective unit for a fee. Estimated costs for the standard warranty are charged to cost of products sold and services delivered when revenue is recorded for the related product. Future warranty costs are estimated based on historical data related to returns and warranty costs on a quarterly basis and this rate is applied to current product sales. Historically, reserve amounts have been increased if management becomes aware of a component failure that could result in larger than anticipated returns from customers. The accrued warranty liability expense is reviewed quarterly to verify that it sufficiently reflects the remaining warranty obligations based on the anticipated expenditures over the balance of the warranty obligation period, and adjustments are made when actual warranty claim experience differs from estimates. Costs related to extended warranties are charged to cost of products sold and services delivered when incurred.

The reserve for warranty returns is included in accrued liabilities on the condensed consolidated balance sheets. The three months ended March 31, 2014 includes additional expense due to a change in estimate regarding the Company’s first generation ETM as a result of an updated version launched in the first quarter. Changes in the Company’s estimated product warranty liabilities are as follows (in thousands):

Three Months Ended March 31,

2014

2013

Balance, January 1,

955

484

Utilization of accrual

(174

)

(157

)

Warranty expense

306

169

Balance, March 31,

1,087

496

Fair Value of Financial Instruments

g. Fair value of financial instruments

The Company uses the fair value framework that prioritizes the inputs to valuation techniques for measuring financial assets and liabilities measured on a recurring basis and for non-financial assets and liabilities when these items are re-measured. Fair value is considered to be the exchange price in an orderly transaction between market participants, to sell an asset or transfer a liability at the measurement date. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. The Company categorizes each of its fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

•

Level 1 – Valuation techniques in which all significant inputs are unadjusted quoted prices from active markets for assets or liabilities that are identical to the assets or liabilities being measured.

•

Level 2 – Valuation techniques in which significant inputs include quoted prices from active markets for assets or liabilities that are similar to the assets or liabilities being measured and/or quoted prices for assets or liabilities that are identical or similar to the assets or liabilities being measured from markets that are not active. Also, model-derived valuations in which all significant inputs and significant value drivers are observable in active markets are Level 2 valuation techniques.

•

Level 3 – Valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Unobservable inputs are valuation technique inputs that reflect our own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The Company has cash equivalents and investments, which at March 31, 2014 and December 31, 2013, were comprised of money market funds, state and municipal obligations, corporate bonds, and certificates of deposits. See additional disclosure regarding the fair value of the Company’s cash equivalents and investments in Note 2. Included in the balance of other assets as of March 31, 2014 is $0.6 million related to corporate-owned life insurance policies which are used to fund the Company’s deferred compensation plan. The Company determines the fair value of its insurance contracts by obtaining the cash surrender value of the contracts from the issuer, a Level 2 valuation technique.

The Company’s financial instruments also include accounts and notes receivable, accounts payable and accrued liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.

Impairment of Long-Lived Assets

h. Impairment of Long-Lived Assets

Management evaluates whether events and circumstances have occurred that indicate the remaining estimated useful life of long-lived assets and identifiable intangible assets may warrant revision or that the remaining balance of these assets may not be recoverable. Such circumstances could include, but are not limited to, a change in the product mix, a change in the way products are created, produced or delivered, or a significant change in the way products are branded and marketed. In performing the review for recoverability, management estimates the future undiscounted cash flows expected to result from the use of the assets and their eventual disposition. The amount of the impairment loss, if impairment exists, is calculated based on the excess of the carrying amounts of the assets over their estimated fair value computed using discounted cash flows. No impairment losses were recorded in the three months ended March 31, 2014 and 2013.

Recently Issued Accounting Guidance

i. Recently issued accounting guidance

In July 2013, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update (“ASU”) to standardize the balance sheet presentation of unrecognized tax benefits. This update applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. The new guidance is effective for fiscal years beginning after December 15, 2013, and early adoption is allowed. The adoption of this guidance resulted in an immaterial reclassification on the Company’s consolidated balance sheet.

Organization_and_Summary_of_Si2

Organization and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Net Sales by Geographic Area	'
	For the three months ended March 31, 2014 and 2013, net sales by geographic area were as follows:


		Three Months Ended March 31,
		2014						2013
	United States	$	25,576			71	%	$	27,314	90	%
	Other Countries		10,609			29			3,120	10

	Total	$	36,185			100	%	$	30,434	100	%


Weighted Average Number of Shares Outstanding and Income Per Share	'

	The calculation of the weighted average number of shares outstanding and income per share are as follows (in thousands except per share data):



		Three Months Ended March 31,
		2014			2013
	Numerator for basic and diluted earnings per share:
	Net income	$	3,391		$	3,298

	Denominator:
	Weighted average shares outstanding—basic		53,190			52,746
	Dilutive effect of stock-based awards		1,934			1,854

	Diluted weighted average shares outstanding		55,124			54,600

	Anti-dilutive stock-based awards excluded		315			1,232

	Net income per common share:
	Basic	$	0.06		$	0.06
	Diluted	$	0.06		$	0.06
Summary of Changes in Estimated Product Warranty Liabilities	'

	Changes in the Company’s estimated product warranty liabilities are as follows (in thousands):



		Three Months Ended March 31,
		2014			2013
	Balance, January 1,	$	955		$	484
	Utilization of accrual		(174	)		(157	)
	Warranty expense		306			169

	Balance, March 31,	$	1,087		$	496

Cash_Cash_Equivalents_and_Inve1

Cash, Cash Equivalents, and Investments (Tables)	3 Months Ended
Cash, Cash Equivalents, and Investments (Tables)	Mar. 31, 2014
Cash And Cash Equivalents [Abstract]	'
Summary of Cash, Cash Equivalents and Held-to-Maturity Investments by Type	'
	The following is a summary of cash, cash equivalents and held-to-maturity investments by type at March 31, 2014 and December 31, 2013 (in thousands):


		March 31, 2014									December 31, 2013
		Amortized Cost		Gross		Gross			Fair Value		Amortized Cost		Gross		Gross			Fair Value
				Unrealized		Unrealized							Unrealized		Unrealized
				Gains		Losses							Gains		Losses
	Cash and money market funds	$	44,897	$	—	$	—		$	44,897	$	42,226	$	—	$	—		$	42,226
	State and municipal obligations		15,213		24		—			15,237		10,807		14		—			10,821
	Corporate bonds		14,781		5		(19	)		14,767		7,743		2		(14	)		7,731
	Certificates of deposit		2,616		—		—			2,616		2,619		—		—			2,619

	Total cash, cash equivalents and investments	$	77,507	$	29	$	(19	)	$	77,517	$	63,395	$	16	$	(14	)	$	63,397


Summary of Amortized Cost and Fair Value of Short-term and Long-term Investments	'
	The following table summarizes the amortized cost and fair value of the short-term and long-term investments held by the Company at March 31, 2014 by contractual maturity (in thousands):


		Amortized Cost		Fair Value
	Due in less than one year	$	17,700	$	17,706
	Due after one year, through two years		14,674		14,677

	Total short-term and long-term investments	$	32,374	$	32,383


Schedule of Company's Investments Measured at Fair Value	'
	The following table presents information about the Company’s investments that are measured at fair value as of March 31, 2014, and indicates the fair value hierarchy of the valuation (in thousands):


		Amortized		Quoted Prices		Siginificant			Significant		Total Fair
		Cost		in Active		Other			Unbservable		Value
				Markets for		Observable			Inputs
				Identical		Inputs			(Level 3)
				Assets		(Level 2)
				(Level 1)
	Cash	$	40,827	$	40,827	$	—		$	—	$	40,827
	Money market funds		4,070		4,070		—			—		4,070
	Certificates of deposit		2,616		—		2,616			—		2,616
	Corporate bonds		14,781		14,767		—			—		14,767
	State and municipal obligations		15,213		—		15,237			—		15,237

	Total cash, cash equivalents and investments	$	77,507	$	59,664	$	17,853		$	—	$	77,517

Inventory_Tables

Inventory (Tables)	3 Months Ended
Inventory (Tables)	Mar. 31, 2014
Inventory Disclosure [Abstract]	'
Inventories	'

	Inventories as of March 31, 2014 and December 31, 2013, consisted of the following (in thousands):



		March 31,			December 31,
		2014			2013
	Raw materials	$	9,201		$	7,376
	Work-in-process		80			44
	Finished goods		4,943			4,688
	Reserve for excess and obsolete inventory		(972	)		(999	)

	Total inventory	$	13,252		$	11,109

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	3 Months Ended
Goodwill and Intangible Assets (Tables)	Mar. 31, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Intangible Assets Other than goodwill	'
	Intangible assets consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):


				March 31, 2014							December 31, 2013
		Useful Life		Gross		Accumulated			Net		Gross		Accumulated			Net Carrying
				Carrying		Amortization			Carrying		Carrying		Amortization			Amount
				Amount					Amount		Amount
	Amortized:
	Domain names	5 Years		$	125	$	(105	)	$	20	$	125	$	(102	)	$	23
	Issued patents	4 to 15 Years			1,557		(456	)		1,101		1,529		(441	)		1,088
	Issued trademarks	9 to 11 Years			372		(159	)		213		437		(147	)		290

	Total amortized				2,054		(720	)		1,334		2,091		(690	)		1,401

	Not amortized:
	TASER trademark				900					900		900					900
	Patents and trademarks pending				1,030					1,030		1,016					1,016

	Total not amortized				1,930					1,930		1,916					1,916

	Total intangible assets			$	3,984	$	(720	)	$	3,264	$	4,007	$	(690	)	$	3,317


Estimated Amortization Expense of Intangible Assets	'
	Estimated amortization expense of intangible assets for the remaining nine months of 2014, the next five years ended December 31, and thereafter is as follows (in thousands):


	2014 (remaining nine months)	$	121
	2015		153
	2016		146
	2017		143
	2018		133
	2019		123
	Thereafter		515

	Total	$	1,334

Deferred_Revenue_Tables

Deferred Revenue (Tables)	3 Months Ended
Deferred Revenue (Tables)	Mar. 31, 2014
Revenue Recognition [Abstract]	'
Summary of Deferred Revenue	'
	Deferred revenue consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):


		March 31		December 31,
		2014		2013
	Warranty	$	16,525	$	15,889
	EVIDENCE.com		4,471		4,026
	Other		530		304

	Total deferred revenue		21,526		20,219
	Total current portion of deferred revenue		7,414		6,878

	Total long-term portion of deferred revenue	$	14,112	$	13,341

Accrued_Liabilities_Tables

Accrued Liabilities (Tables)	3 Months Ended
Accrued Liabilities (Tables)	Mar. 31, 2014
Payables And Accruals [Abstract]	'
Accrued Liabilities	'
	Accrued liabilities consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):


		March 31,		December 31,
		2014		2013
	Accrued salaries and benefits	$	2,188	$	2,328
	Accrued judgments and settlements		3,300		3,350
	Accrued warranty expense		1,087		955
	Accrued income and other taxes		140		233
	Other accrued expenses		2,692		1,974

	Accrued liabilities	$	9,407	$	8,840

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	3 Months Ended
Stockholders' Equity (Tables)	Mar. 31, 2014
Equity [Abstract]	'
Summary of Restricted Stock Unit Activity	'
	The following table summarizes RSU activity for the three months ended March 31, 2014 (aggregate intrinsic value in thousands):


		Number of			Weighted		Aggregate
		Units			Average Grant-		Intrinsic Value
					Date Fair
					Value
	Units outstanding, beginning of period		1,279,123		$	9.67
	Granted		374,947			17.58
	Released		(302,194	)		7.51
	Forfeited		(107,070	)		13.57

	Units outstanding, end of period		1,244,806			12.25	$	22,768




Summary of the Company's Stock Options Activity	'
	The following table summarizes stock option activity for the three months ended March 31, 2014 (aggregate intrinsic value in thousands):


		Number of			Weighted		Average		Aggregate
		options			Average		Remaining		Intrinsic Value
					Exercise Price		Contractual
							Life (years)
	Options outstanding, beginning of period		3,365,692		$	6.15
	Granted		—
	Exercised		(1,027,600	)		7.08
	Expired / forfeited		(27,134	)		9.77

	Options outstanding, end of period		2,310,958			5.69		5.02	$	29,213

	Exercisable at March 31, 2014		2,200,443			5.75		4.95		27,697

	Expected to vest after March 31, 2014		68,150			4.49		7.02		940


Share-Based Compensation	'
	Share-based compensation was classified as follows (in thousands):


		Three Months Ended March 31,
		2014			2013
	Cost of products sold	$	22		$	34
	Sales, general and administrative expenses		711			731
	Research and development expenses		444			158

	Total share-based compensation	$	1,177		$	923

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2014

Commitments And Contingencies Disclosure [Abstract]

Loss Contingencies

Plaintiff

Served

Jurisdiction

Claim Type

Status

Grable

8-Aug

6th Judicial Circuit Court, Pinellas County, FL

Training Injury

Discovery Phase

Koon

8-Dec

17th Judicial Circuit Court, Broward County, FL

Training Injury

Discovery Phase

Derbyshire

9-Nov

Ontario, Canada Superior Court of Justice

Officer Injury

Discovery Phase

Thompson

10-Mar

11th Judicial Circuit Court, Miami-Dade County, FL

Suspect Injury During Arrest

Discovery Phase

Doan

10-Apr

The Queens Bench Alberta, Red Deer Judicial Dist.

Wrongful Death

Discovery Phase

Shymko

10-Dec

The Queens Bench, Winnipeg Centre, Manitoba

Wrongful Death

Pleading Phase

Juran

10-Dec

Hennepin County District Court, 4th Judicial District

Officer Injury

Discovery Phase

Wilson

11-May

US District Court, ED MO

Wrongful Death

Discovery Phase; trial

scheduled for Nov. 2014

Ramsey

12-Jan

17th Judicial Circuit Court, Broward County, FL

Wrongful Death

Discovery Phase

Mitchell

12-Apr

US District Court, ED MI

Wrongful Death

Discovery Phase; trial

scheduled June 2014

Firman

12-Apr

Ontario, Canada Superior Court of Justice

Wrongful Death

Pleading Phase

Ricks

12-May

US District Court, WD LA

Wrongful Death

Motion Phase

Miller

13-Jan

New Castle County Superior Court, DE

Wrongful Death

Discovery Phase

Salgado

13-Feb

US District Court, SD FL

Wrongful Death

Pleading Phase

Slade

13-Dec

US District Court, ED TX

Wrongful Death

Pleading Phase

McCue

14-Mar

US District Court, District of Maine

Wrongful Death

Pleading Phase

Faltesek

14-Apr

Harris County District Court, TX

Wrongful Death

Pleading Phase

Rascom

14-Apr

US District Court, AZ

Wrongful Death

Pleading Phase

Summary of Other Product Litigation Matters

In addition, other product litigation matters in which the Company is involved that are currently on appeal are listed below:

Plaintiff

Served

Jurisdiction

Claim Type

Status

Glowczenski

4-Oct

US District Court, ED NY

Wrongful Death

Notice of Appeal filed Sept. 2013; Opening Brief was filed Jan. 2014; Answering Brief is due Apr. 2014.

Summary of Cases Dismissed or Judgment Entered

Plaintiff

Served

Jurisdiction

Claim Type

Status

Athetis

9-May

Superior Court, AZ

Wrongful Death

Motion for Summary Judgment

Duensing

12-Feb

US District Court, NV

Suspect Injury During Arrest

Motion to Dismiss

Wingard

12-Oct

US District Court, WD PA

Wrongful Death

Voluntary Dismissal

Manjares

12-Nov

US District Court, ED WA

Suspect Injury During Arrest

Voluntary Dismissal

Turner

10-Feb

US District Court, ED NC

Wrongful Death

Settled and dismissed

Information Regarding the Company's Insurance Coverage

The following table provides information regarding the Company’s product liability insurance. Remaining insurance coverage is based on information received from the Company’s insurance provider (in millions).

Policy Year

Policy Start

Policy End

Insurance

Deductible

Defense

Remaining

Active Cases and Cases on Appeal

Date

Coverage

Amount

Costs

Insurance

Covered

Coverage

2004

12/1/03

12/1/04

0.1

Glowczenski

2005

12/1/04

12/1/05

0.3

n/a

2006

12/1/05

12/1/06

0.3

3.7

n/a

2007

12/1/06

12/1/07

0.3

n/a

2008

12/1/07

12/15/08

0.5

—

Grable, Koon

2009

12/15/08

12/15/09

Derbyshire

2010

12/15/09

12/15/10

Thompson, Shymko, Doan, Juran

2011

12/15/10

12/15/11

Wilson

Jan – Jun 2012

12/15/11

6/25/12

Ramsey, Mitchell, Firman, Ricks

Jul – Dec 2012

6/25/12

12/15/12

n/a

2013

12/15/12

12/15/13

Miller, Salgado

2014

12/15/13

12/15/14

Slade, McCue, Rascom, Faltesek

Segment_Data_Tables

Segment Data (Tables)	3 Months Ended
Segment Data (Tables)	Mar. 31, 2014
Segment Reporting [Abstract]	'
Summary of Operational Information Relative to the Company's Reportable Segments	'
	Information relative to the Company’s reportable segments is as follows (in thousands):


		Three Months Ended March 31, 2014							Three Months Ended March 31, 2013
		TASER		EVIDENCE.com					TASER		EVIDENCE.com
		Weapons		& Video			Total		Weapons		& Video			Total
	Product sales	$	32,475	$	3,038		$	35,513	$	28,003	$	2,180		$	30,183
	Service revenue		—		672			672		—		251			251

	Net sales		32,475		3,710			36,185		28,003		2,431			30,434

	Cost of products sold		10,918		2,656			13,574		10,217		1,188			11,405
	Cost of services delivered		—		403			403		—		578			578

	Gross margin		21,557		651			22,208		17,786		665			18,451
	Sales, general & administrative		11,289		2,457			13,746		10,073		1,108			11,181
	Research & development		817		2,789			3,606		989		1,024			2,013

	Income (loss) from operations	$	9,451	$	(4,595	)	$	4,856	$	6,724	$	(1,467	)	$	5,257

	Purchases of property and equipment	$	697	$	102		$	799	$	254	$	129		$	383
	Purchases of intangible assets		67		—			67		104		—			104
	Depreciation and amortization		1,078		84			1,162		999		420			1,419

Organization_and_Summary_of_Si3

Organization and Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Source

Total Net Sales [Member]

Customer Concentration Risk [Member]

Distributor [Member]

Individual Country Outside of the United States [Member]

Maximum [Member]

Minimum [Member]

Extended Product Warranty [Member]

Segment

Total Net Sales [Member]

Accounts Receivable [Member]

Total Net Sales [Member]

Geographic Concentration Risk [Member]

Customer Concentration Risk [Member]

Individual Country Outside of the United States [Member]

Maximum [Member]

Minimum [Member]

Total Net Sales [Member]

Accounts Receivable [Member]

Customer Concentration Risk [Member]

Customer

Total Net Sales [Member]

Summary Of Significant Accounting Policy [Line Items]

Number of reportable segments of company

Aggregated operating segments

Sales to customers, countries outside of the United States

Percentage of risk concentration

100.00%

10.00%

10.30%

17.40%

13.70%

11.00%

10.00%

Number of revenue sources

Period of extended warranty after expiration of standard warranty

'5 years

'1 year

Service term for services purchased

'5 years

'1 year

Contractual Period of entities assurance program

'5 years

'3 years

Note receivable in term

'5 years

Company receive payment

'30 days

Accounts and notes receivable related to purchases

$0.20

Warranty period

'1 year

Corporate owned life insurance policies fair value

0.6

Impairment charge

Organization_and_Summary_of_Si4

Organization and Summary of Significant Accounting Policies - Net Sales by Geographic Area (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]	'	'
Net sales by Geographic Area	$36,185	$30,434
Total Net Sales [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales by Geographic Area	36,185	30,434
Percentage of Net sales by Geographic Area	100.00%	100.00%
United States [Member] \| Total Net Sales [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales by Geographic Area	25,576	27,314
Percentage of Net sales by Geographic Area	71.00%	90.00%
Other Countries [Member] \| Total Net Sales [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net sales by Geographic Area	$10,609	$3,120
Percentage of Net sales by Geographic Area	29.00%	10.00%

Organization_and_Summary_of_Si5

Organization and Summary of Significant Accounting Policies - Weighted Average Number of Shares Outstanding and Income Per Share (Detail) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Numerator for basic and diluted earnings per share:	'	'
Net income	$3,391	$3,298
Denominator:	'	'
Weighted average shares outstanding-basic	53,190	52,746
Dilutive effect of stock-based awards	1,934	1,854
Diluted weighted average shares outstanding	55,124	54,600
Anti-dilutive stock-based awards excluded	315	1,232
Net income per common share:	'	'
Basic	$0.06	$0.06
Diluted	$0.06	$0.06

Organization_and_Summary_of_Si6

Organization and Summary of Significant Accounting Policies - Summary of Changes in Estimated Product Warranty Liabilities (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'	'
Balance, January 1,	$955	$484
Utilization of accrual	-174	-157
Warranty expense	306	169
Balance, March 31,	$1,087	$496

Cash_Cash_Equivalents_and_Inve2

Cash, Cash Equivalents, and Investments - Summary of Cash, Cash Equivalents and Held-to-Maturity Investments by Type (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Amortized Cost	$77,507	$63,395
Gross Unrealized Gains	29	16
Gross Unrealized Losses	-19	-14
Fair Value	77,517	63,397
Cash and Money Market Funds [Member]	'	'
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Amortized Cost	44,897	42,226
Gross Unrealized Gains	'	'
Gross Unrealized Losses	'	'
Fair Value	44,897	42,226
State and Municipal Obligations [Member]	'	'
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Amortized Cost	15,213	10,807
Gross Unrealized Gains	24	14
Gross Unrealized Losses	'	'
Fair Value	15,237	10,821
Corporate Bonds [Member]	'	'
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Amortized Cost	14,781	7,743
Gross Unrealized Gains	5	2
Gross Unrealized Losses	-19	-14
Fair Value	14,767	7,731
Certificates of Deposit [Member]	'	'
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Amortized Cost	2,616	2,619
Gross Unrealized Gains	'	'
Gross Unrealized Losses	'	'
Fair Value	$2,616	$2,619

Cash_Cash_Equivalents_and_Inve3

Cash, Cash Equivalents, and Investments - Summary of Amortized Cost and Fair Value of Short-term and Long-term Investments (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Due in less than one year	$17,700	$9,101
Due after one year, through two years	14,674	12,023
Amortized Cost [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Due in less than one year	17,700	'
Due after one year, through two years	14,674	'
Total short-term and long-term investments	32,374	'
Fair Value [Member]	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Due in less than one year	17,706	'
Due after one year, through two years	14,677	'
Total short-term and long-term investments	$32,383	'

Cash_Cash_Equivalents_and_Inve4

Cash, Cash Equivalents and Investments - Schedule of Company's Investments Measured at Fair Value (Detail) (USD $)	Mar. 31, 2014
In Thousands, unless otherwise specified	Mar. 31, 2014
Cash And Short Term Investments [Line Items]	'
Amortized Cost	$77,507
Total Fair Value	77,517
Corporate Bonds [Member]	'
Cash And Short Term Investments [Line Items]	'
Amortized Cost	14,781
Total Fair Value	14,767
State and Municipal Obligations [Member]	'
Cash And Short Term Investments [Line Items]	'
Amortized Cost	15,213
Total Fair Value	15,237
Cash [Member]	'
Cash And Short Term Investments [Line Items]	'
Amortized Cost	40,827
Total Fair Value	40,827
Money Market Funds [Member]	'
Cash And Short Term Investments [Line Items]	'
Amortized Cost	4,070
Total Fair Value	4,070
Certificates of Deposit [Member]	'
Cash And Short Term Investments [Line Items]	'
Amortized Cost	2,616
Total Fair Value	2,616
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	59,664
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| Corporate Bonds [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	14,767
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| State and Municipal Obligations [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| Cash [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	40,827
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| Money Market Funds [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	4,070
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] \| Certificates of Deposit [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Other Observable Inputs (Level 2) [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	17,853
Significant Other Observable Inputs (Level 2) [Member] \| Corporate Bonds [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Other Observable Inputs (Level 2) [Member] \| State and Municipal Obligations [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	15,237
Significant Other Observable Inputs (Level 2) [Member] \| Cash [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Other Observable Inputs (Level 2) [Member] \| Money Market Funds [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Other Observable Inputs (Level 2) [Member] \| Certificates of Deposit [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	2,616
Significant Unobservable Inputs (Level 3) [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Unobservable Inputs (Level 3) [Member] \| Corporate Bonds [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Unobservable Inputs (Level 3) [Member] \| State and Municipal Obligations [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Unobservable Inputs (Level 3) [Member] \| Cash [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Unobservable Inputs (Level 3) [Member] \| Money Market Funds [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'
Significant Unobservable Inputs (Level 3) [Member] \| Certificates of Deposit [Member]	'
Cash And Short Term Investments [Line Items]	'
Total Fair Value	'

Inventory_Inventories_Detail

Inventory - Inventories (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Inventory Disclosure [Abstract]	'	'
Raw materials	$9,201	$7,376
Work-in-process	80	44
Finished goods	4,943	4,688
Reserve for excess and obsolete inventory	-972	-999
Total inventory	$13,252	$11,109

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'	'	'
Goodwill	$2,235,000	'	$2,235,000
Amortization expense	$40,000	$38,000	'

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets - Intangible Assets Other than Goodwill (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Not amortized intangible assets, Carrying Amount	$1,930	$1,916
Amortized intangible assets, Gross Carrying Amount	2,054	2,091
Intangible assets, Gross Carrying Amount	3,984	4,007
Accumulated Amortization	-720	-690
Amortized intangible assets, Net Carrying Amount	1,334	1,401
Intangible assets, Net Carrying Amount	3,264	3,317
Domain Names [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Amortized intangible assets, Useful Life	'5 years	'
Amortized intangible assets, Gross Carrying Amount	125	125
Accumulated Amortization	-105	-102
Amortized intangible assets, Net Carrying Amount	20	23
Issued Patents [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Amortized intangible assets, Gross Carrying Amount	1,557	1,529
Accumulated Amortization	-456	-441
Amortized intangible assets, Net Carrying Amount	1,101	1,088
Issued Patents [Member] \| Minimum [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Amortized intangible assets, Useful Life	'4 years	'
Issued Patents [Member] \| Maximum [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Amortized intangible assets, Useful Life	'15 years	'
Issued Trademarks [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Amortized intangible assets, Gross Carrying Amount	372	437
Accumulated Amortization	-159	-147
Amortized intangible assets, Net Carrying Amount	213	290
Issued Trademarks [Member] \| Minimum [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Amortized intangible assets, Useful Life	'9 years	'
Issued Trademarks [Member] \| Maximum [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Amortized intangible assets, Useful Life	'11 years	'
TASER Trademark [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Not amortized intangible assets, Carrying Amount	900	900
Patents and Trademarks Pending [Member]	'	'
Acquired Indefinite-lived Intangible Assets [Line Items]	'	'
Not amortized intangible assets, Carrying Amount	$1,030	$1,016

Recovered_Sheet1

Goodwill and Intangible assets - Estimated Amortization Expense of Intangible Assets (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'	'
2014 (remaining nine months)	$121	'
2015	153	'
2016	146	'
2017	143	'
2018	133	'
2019	123	'
Thereafter	515	'
Amortized intangible assets, Net Carrying Amount	$1,334	$1,401

Deferred_Revenue_Summary_of_De

Deferred Revenue - Summary of Deferred Revenue (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]	'	'
Total deferred revenue	$21,526	$20,219
Total current portion of deferred revenue	7,414	6,878
Total long-term portion of deferred revenue	14,112	13,341
Warranty [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Total deferred revenue	16,525	15,889
Total current portion of deferred revenue	5,300	'
EVIDENCE.com [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Total deferred revenue	4,471	4,026
Total current portion of deferred revenue	2,100	'
Other [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Total deferred revenue	$530	$304

Deferred_Revenue_Additional_In

Deferred Revenue - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]	'	'
Total current portion of deferred revenue	$7,414	$6,878
EVIDENCE.com [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Total current portion of deferred revenue	2,100	'
Warranty [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Total current portion of deferred revenue	$5,300	'

Accrued_Liabilities_Accrued_Li

Accrued Liabilities - Accrued Liabilities (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
Payables And Accruals [Abstract]	'	'	'	'
Accrued salaries and benefits	$2,188	$2,328	'	'
Accrued judgments and settlements	3,300	3,350	'	'
Accrued warranty expense	1,087	955	496	484
Accrued income and other taxes	140	233	'	'
Other accrued expenses	2,692	1,974	'	'
Accrued liabilities	$9,407	$8,840	'	'

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Income Tax Disclosure [Line Items]	'
Total current and long term deferred tax assets	$19.10
Research and development tax credit studies	10.1
Liability for unrecognized tax benefits	3.1
Overall effective tax rate, after discrete period adjustments	30.60%
Effective tax rate, before discrete period adjustments	39.10%
Federal [Member]	'
Income Tax Disclosure [Line Items]	'
Liability for unrecognized tax benefits	3
State [Member]	'
Income Tax Disclosure [Line Items]	'
Liability for unrecognized tax benefits	0.1
Research and Development Credits [Member]	'
Income Tax Disclosure [Line Items]	'
Unrecognized tax benefit associated with research and development credits that has been netted against the research and development credit deferred tax asset	$1.30

Stockholders_Equity_Additional

Stockholders' Equity - Additional Information (Detail) (USD $)

0 Months Ended

3 Months Ended

23-May-13

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Restricted Stock [Member]

Stock Options [Member]

Performance Based Stock Options [Member]

Performance Based Restricted Stock Unit [Member]

Restricted Stock Units (RSUs) [Member]

Incentive Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock incentive plan

1,600,000

Option available for future grants

2,000,000

Aggregate intrinsic value price per share

$18.29

Unrecognized stock-based compensation cost

$12,900,000

$100,000

Weighted average period

'31 months 15 days

Approximate units of performance restricted stock granted

100,000

Approximate units outstanding

1,244,806

1,279,123

300,000

Performance criteria met for approximate units

302,194

100,000

Maximum additional shares

100,000

Shares withheld, for net share settlement of share based award

100,000

Tax payments, for net share settlement of share based award

1,138,000

178,000

1,100,000

Aggregate intrinsic value, options exercisable

27,697,000

1,600,000

Weighted average vesting period

'10 months

Performance-based stock options Cumulative Granted

400,000

Unvested performance options

40,000

Number of options awarded

Incremental stock option expense

$8,000

$39,000

Stockholders_Equity_Summary_of

Stockholders' Equity - Summary of Restricted Stock Unit Activity (Detail) (Restricted Stock [Member], USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014
Restricted Stock [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Units outstanding, beginning of period	1,279,123
Number of Units, Granted	374,947
Number of Units, Released	-302,194
Number of Units, Forfeited	-107,070
Number of Units outstanding, end of period	1,244,806
Weighted Average Grant Date Fair Value, Units outstanding, beginning of period	$9.67
Weighted Average Grant Date Fair Value, Granted	$17.58
Weighted Average Grant Date Fair Value, Released	$7.51
Weighted Average Grant Date Fair Value, Forfeited	$13.57
Weighted Average Grant Date Fair Value, Units outstanding, end of period	$12.25
Aggregate intrinsic value, Units outstanding, end of period	$22,768

Stockholders_Equity_Summary_of1

Stockholders' Equity - Summary of the Company's Stock Options Activity (Detail) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of options, Granted	0	0
Stock Options [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Number of options, Options outstanding, beginning of period	3,365,692	'
Number of options, Granted	'	'
Number of options, Exercised	-1,027,600	'
Number of options, Expired / forfeited	-27,134	'
Number of options, Options outstanding, end of period	2,310,958	'
Number of options, Options exercisable, end of period	2,200,443	'
Number of options, Options expected to vest, end of period	'	'
Weighted average exercise price, Options outstanding, beginning of period	6.15	'
Weighted average exercise price, Granted	'	'
Weighted average exercise price, Exercised	7.08	'
Weighted average exercise price, Expired / forfeited	9.77	'
Weighted average exercise price, Options outstanding, end of period	5.69	'
Weighted average exercise price, Options exercisable, end of period	5.75	'
Weighted average exercise price, Options expected to vest, end of period	4.49	'
Weighted Average Remaining Contractual Life (years), Options outstanding, end of period	'5 years 7 days	'
Weighted Average Remaining Contractual Life (years), Options exercisable, end of period	'4 years 11 months 12 days	'
Weighted Average Remaining Contractual Life (years), Options expected to vest, end of period	'7 years 7 days	'
Aggregate intrinsic value, Options outstanding, end of period	29,213	'
Aggregate intrinsic value, Options exercisable, end of period	27,697	1,600
Aggregate intrinsic value, Options expected to vest, end of period	940	'

Stockholders_Equity_Reported_S

Stockholders' Equity - Reported Share-Based Compensation (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total share-based compensation	$1,177	$923
Cost of Products Sold [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total share-based compensation	22	34
Sales, General and Administrative Expenses [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total share-based compensation	711	731
Research and Development Expenses [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Total share-based compensation	$444	$158

Line_of_Credit_Additional_Info

Line of Credit - Additional Information (Detail) (USD $)	3 Months Ended
Line of Credit - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Debt Disclosure [Abstract]	'	'
Total availability under line of credit agreement	$10,000,000	'
Letters of credit outstanding amount	600,000	'
Available borrowing under letter of credit	9,400,000	'
Varying Interest on Line of credit agreement	'LIBOR plus 1.5% to prime	'
Line of credit interest rate	1.50%	'
Maturity date of line of credit	30-Jun-15	'
Line of credit facility amount outstanding	$0	$0
Maximum ratio of total liabilities to tangible net worth	1	'
Minimum required fixed coverage charge ratio	1.25	'
Period used for calculating ratios	'12 months	'
Company's tangible net worth ratio	0.34	'
Fixed coverage charge ratio	3.26	'

Commitments_and_Contingencies_1

Commitments and Contingencies - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

1 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2014

Sep. 30, 2011

Dec. 31, 2012

Dec. 31, 2013

Feb. 28, 2014

Mar. 31, 2012

Jul. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

4-May-12

Apr. 20, 2012

Dec. 31, 2013

Cases

AA And Saba Consultants [Member]

Slade [Member]

Ramsey [Member]

Lawsuits

Loss Contingencies [Line Items]

Number of lawsuits against Company

Number of lawsuit

Number of active product liability cases

Jury decision against company

$10

Litigation judgment

3.3

Jury award value

4.4

Jury decision against company which adjusted to award

5.5

Benefit on reversal of accrued litigation

2.2

Benefit on reversal of accrued litigation leaving a reserve

1.1

Settlement amount of litigation

3.4

Litigation settlement saving off

2.1

Litigation settlement Judgement vacated on appeal

5.5

Litigation settlement payment by insurance

2.7

Litigation settlement amount payable

0.7

Amount of settlement offer

0.8

Verdict against the company

3.3

Loss contingency loss in period

$2.60

Commitments_and_Contingencies_2

Commitments and Contingencies - Loss Contingencies (Detail)	3 Months Ended
Commitments and Contingencies - Loss Contingencies (Detail)	Mar. 31, 2014
Grable [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Grable
Month Served	'Aug-08
Jurisdiction	'6th Judicial Circuit Court, Pinellas County, FL
Claim Type	'Training Injury
Status	'Discovery Phase
Koon [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Koon
Month Served	'Dec-08
Jurisdiction	'17th Judicial Circuit Court, Broward County, FL
Claim Type	'Training Injury
Status	'Discovery Phase
Derbyshire [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Derbyshire
Month Served	'Nov-09
Jurisdiction	'Ontario, Canada Superior Court of Justice
Claim Type	'Officer Injury
Status	'Discovery Phase
Thompson [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Thompson
Month Served	'Mar-10
Jurisdiction	'11th Judicial Circuit Court, Miami-Dade County, FL
Claim Type	'Suspect Injury During Arrest
Status	'Discovery Phase
Doan [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Doan
Month Served	'Apr-10
Jurisdiction	'The Queens Bench Alberta, Red Deer Judicial Dist.
Claim Type	'Wrongful Death
Status	'Discovery Phase
Shymko [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Shymko
Month Served	'Dec-10
Jurisdiction	'The Queens Bench, Winnipeg Centre, Manitoba
Claim Type	'Wrongful Death
Status	'Pleading Phase
Juran [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Juran
Month Served	'Dec-10
Jurisdiction	'Hennepin County District Court, 4th Judicial District
Claim Type	'Officer Injury
Status	'Discovery Phase
Wilson [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Wilson
Month Served	'May-11
Jurisdiction	'US District Court, ED MO
Claim Type	'Wrongful Death
Status	'Discovery Phase; trial scheduled for Nov. 2014
Ramsey [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Ramsey
Month Served	'Jan-12
Jurisdiction	'17th Judicial Circuit Court, Broward County, FL
Claim Type	'Wrongful Death
Status	'Discovery Phase
Mitchell [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Mitchell
Month Served	'Apr-12
Jurisdiction	'US District Court, ED MI
Claim Type	'Wrongful Death
Status	'Discovery Phase; trial scheduled June 2014
Firman [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Firman
Month Served	'Apr-12
Jurisdiction	'Ontario, Canada Superior Court of Justice
Claim Type	'Wrongful Death
Status	'Pleading Phase
Ricks [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Ricks
Month Served	'May-12
Jurisdiction	'US District Court, WD LA
Claim Type	'Wrongful Death
Status	'Motion Phase
Miller [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Miller
Month Served	'Jan-13
Jurisdiction	'New Castle County Superior Court, DE
Claim Type	'Wrongful Death
Status	'Discovery Phase
Salgado [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Salgado
Month Served	'Feb-13
Jurisdiction	'US District Court, SD FL
Claim Type	'Wrongful Death
Status	'Pleading Phase
Slade [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Slade
Month Served	'Dec-13
Jurisdiction	'US District Court, ED TX
Claim Type	'Wrongful Death
Status	'Pleading Phase
McCue [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'McCue
Month Served	'Mar-14
Jurisdiction	'US District Court, District of Maine
Claim Type	'Wrongful Death
Status	'Pleading Phase
Faltesek [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Faltesek
Month Served	'Apr-14
Jurisdiction	'Harris Country District Court, TX
Claim Type	'Wrongful Death
Status	'Pleading Phase
Rascom [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Rascom
Month Served	'Apr-14
Jurisdiction	'US District Court, AZ
Claim Type	'Wrongful Death
Status	'Pleading Phase

Commitments_and_Contingencies_3

Commitments and Contingencies - Summary of Other Litigation Matters (Detail) (Pending Litigation [Member], Glowczenski [Member])	3 Months Ended
	Mar. 31, 2014
Pending Litigation [Member] \| Glowczenski [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Glowczenski
Served	'Oct-04
Jurisdiction	'US District Court, ED NY
Claim Type	'Wrongful Death
Status	'Notice of Appeal filed Sept. 2013; Opening Brief was filed Jan. 2014; Answering Brief is due Apr. 2014.

Commitments_and_Contingencies_4

Commitments and Contingencies - Summary of Cases Dismissed or Judgment Entered (Detail)	3 Months Ended
	Mar. 31, 2014
Athetis [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Athetis
Month Served	'May-09
Jurisdiction	'Superior Court, AZ
Claim Type	'Wrongful Death
Status	'Motion for Summary Judgment
Duensing [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Duensing
Month Served	'Feb-12
Jurisdiction	'US District Court, NV
Claim Type	'Suspect Injury During Arrest
Status	'Motion to Dismiss
Wingard [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Wingard
Month Served	'Oct-12
Jurisdiction	'US District Court, WD PA
Claim Type	'Wrongful Death
Status	'Voluntary Dismissal
Manjares [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Manjares
Month Served	'Nov-12
Jurisdiction	'US District Court, ED WA
Claim Type	'Suspect Injury During Arrest
Status	'Voluntary Dismissal
Turner [Member]	'
Loss Contingencies [Line Items]	'
Plaintiff	'Turner
Month Served	'Feb-10
Jurisdiction	'US District Court, ED NC
Claim Type	'Wrongful Death
Status	'Settled and dismissed

Commitments_and_Contingencies_5

Commitments and Contingencies - Information Regarding the Company's Insurance Coverage (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
2004 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2004
Policy Start Date	1-Dec-13
Policy End Date	1-Dec-04
Insurance Coverage	$2
Deductible Amount	0.1
Defense Costs Covered	'N
Remaining Insurance Coverage	2
Active Cases and Cases on Appeal	'Glowczenski
2005 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2005
Policy Start Date	1-Dec-04
Policy End Date	1-Dec-05
Insurance Coverage	10
Deductible Amount	0.3
Defense Costs Covered	'Y
Remaining Insurance Coverage	7
Active Cases and Cases on Appeal	'n/a
2006 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2006
Policy Start Date	1-Dec-05
Policy End Date	1-Dec-06
Insurance Coverage	10
Deductible Amount	0.3
Defense Costs Covered	'Y
Remaining Insurance Coverage	3.7
Active Cases and Cases on Appeal	'n/a
2007 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2007
Policy Start Date	1-Dec-06
Policy End Date	1-Dec-07
Insurance Coverage	10
Deductible Amount	0.3
Defense Costs Covered	'Y
Remaining Insurance Coverage	8
Active Cases and Cases on Appeal	'n/a
2008 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2008
Policy Start Date	1-Dec-07
Policy End Date	15-Dec-08
Insurance Coverage	10
Deductible Amount	0.5
Defense Costs Covered	'Y
Remaining Insurance Coverage	'
Active Cases and Cases on Appeal	'Grable, Koon,
2009 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2009
Policy Start Date	15-Dec-08
Policy End Date	15-Dec-09
Insurance Coverage	10
Deductible Amount	1
Defense Costs Covered	'N
Remaining Insurance Coverage	10
Active Cases and Cases on Appeal	'Derbyshire
2010 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2010
Policy Start Date	15-Dec-09
Policy End Date	15-Dec-10
Insurance Coverage	10
Deductible Amount	1
Defense Costs Covered	'N
Remaining Insurance Coverage	10
Active Cases and Cases on Appeal	'Thompson, Shymko, Doan, Juran
2011 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2011
Policy Start Date	15-Dec-10
Policy End Date	15-Dec-11
Insurance Coverage	10
Deductible Amount	1
Defense Costs Covered	'N
Remaining Insurance Coverage	10
Active Cases and Cases on Appeal	'Wilson,
Jan - Jun 2012 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Start Date	15-Dec-11
Policy End Date	25-Jun-12
Insurance Coverage	7
Deductible Amount	1
Defense Costs Covered	'N
Remaining Insurance Coverage	7
Active Cases and Cases on Appeal	'Ramsey, Mitchell, Firman, Ricks
Jul - Dec 2012 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Start Date	25-Jun-12
Policy End Date	15-Dec-12
Insurance Coverage	12
Deductible Amount	1
Defense Costs Covered	'N
Remaining Insurance Coverage	12
Active Cases and Cases on Appeal	'n/a
2013 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2013
Policy Start Date	15-Dec-12
Policy End Date	15-Dec-13
Insurance Coverage	12
Deductible Amount	1
Defense Costs Covered	'N
Remaining Insurance Coverage	12
Active Cases and Cases on Appeal	'Miller, Salgado
2014 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Year	'2014
Policy Start Date	15-Dec-13
Policy End Date	15-Dec-14
Insurance Coverage	12
Deductible Amount	4
Defense Costs Covered	'N
Remaining Insurance Coverage	$12
Active Cases and Cases on Appeal	'Slade, McCue, Rascom, Faltesek
Minimum [Member] \| Jan - Jun 2012 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Month Year	'2012-01
Minimum [Member] \| Jul - Dec 2012 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Month Year	'2012-07
Maximum [Member] \| Jan - Jun 2012 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Month Year	'2012-06
Maximum [Member] \| Jul - Dec 2012 [Member]	'
Product Liability Contingency [Line Items]	'
Policy Month Year	'2012-12

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (Consulting Services [Member], USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013
Consulting Services [Member]	'	'	'
Related Party Transaction [Line Items]	'	'	'
Outstanding payables due to related party	$31,000	'	$30,000
Transaction expenses incurred by parent company	$15,000	$12,000	'

Employee_Benefit_Plans_Additio

Employee Benefit Plans - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Compensation And Retirement Disclosure [Abstract]	'	'
Non-qualified deferred compensation plan allowable eligible participants deferral percentage of base salary	80.00%	'
Non-qualified deferred compensation plan allowable eligible participants deferral percentage of other compensation	100.00%	'
Employee deferrals deemed vested percentage upon contribution	100.00%	'
Company's contributions to the plan	$200,000	$200,000
Company's expected contributions to the plan	$8,000	'

Segment_Data_Additional_Inform

Segment Data - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2014
	Segment
Segment Reporting [Abstract]	'
Number of reportable segments of company	2

Segment_Data_Summary_of_Operat

Segment Data - Summary of Operational Information Relative to the Company's Reportable Segments (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]	'	'
Product sales	$35,513	$30,183
Service revenue	672	251
Net sales	36,185	30,434
Cost of products sold	13,574	11,405
Cost of services delivered	403	578
Gross margin	22,208	18,451
Sales, general & administrative	13,746	11,181
Research & development	3,606	2,013
Income (loss) from operations	4,856	5,257
Purchases of property and equipment	799	383
Purchases of intangible assets	67	104
Depreciation and amortization	1,162	1,419
TASER Weapons [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Product sales	32,475	28,003
Service revenue	'	'
Net sales	32,475	28,003
Cost of products sold	10,918	10,217
Cost of services delivered	'	'
Gross margin	21,557	17,786
Sales, general & administrative	11,289	10,073
Research & development	817	989
Income (loss) from operations	9,451	6,724
Purchases of property and equipment	697	254
Purchases of intangible assets	67	104
Depreciation and amortization	1,078	999
Evidence.com & Video [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Product sales	3,038	2,180
Service revenue	672	251
Net sales	3,710	2,431
Cost of products sold	2,656	1,188
Cost of services delivered	403	578
Gross margin	651	665
Sales, general & administrative	2,457	1,108
Research & development	2,789	1,024
Income (loss) from operations	-4,595	-1,467
Purchases of property and equipment	102	129
Purchases of intangible assets	'	'
Depreciation and amortization	$84	$420